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CHAPTER 1: INTRODUCTION OF GLUCOAMYLASE 
General Introduction 
Glucoajnylase is an exo-acting caxbohydrase that catalyzes the release of 3-D -glucose 
from the nonreducing ends of starch chains. Although its official lUPAC-IUB name is 
1.4-Qf-D-glucan glucohydrolase (E.G.3.2.1.3.). its common name is glucoamylase. In 
early literature, glucoamylase was called amyloglucosidase. saccharogenic amylase, gluc-
amylaise. a-glucosidase. A-ajnylase, glucogenic enzyme, st«irch glucogenase. 7 amylase. 
exo-1.4-Q-D-glucan-glucajiohydrolase and saccharifying ajnylase. In this thesis. I will 
refer the enzyme ais glucoamylase. GA. 
Glucoamylase is primarily a microbiaJ enzyme. However, glucoamylase activity is 
observed in plants and animals as well [1]. Fungi ajid yeast are the primary sources of 
this enzyme. Glucoamylase hais been obtained from several fungi e.g.. Aspergillus niger, 
Aspergillus foetidus, Aspergillus oryzae, Aspergillus phoenics, Aspergillus awamori. .45-
pergillus saitoi. Aspergillus candidus, Aspergillus batatae, Aspergillus cinnamomeus. Rhi-
zopus delemar, Rhizopus javanicus , to name a few [Ij. Certain yeast such as Sac-
charomyces diastaticus, Saccharomyces cerevisiae, Saccharomyces pombe and Saccha-
romycorsis fibuligera produce glucoamylase [1]. Only a few bacteria including Bacillus 
sterrothermophilus, Clostridium thermohydrosulfuricum, Halobacterium sodomense, and 
Clostridium acetobutylicum produce glucoamylase [2]. 
Although glucoamylzises from fungi axe secreted, bacterial glucoamylases from flavobac-
terium species are tightly cell-bound, whereas in C. thermohydrosulfuricum both intra­
cellular and membrane bound glucoamylcises have been observed. 
Fungal and yeast glucoamylases are glycoproteins containing covalently linked carbo­
hydrate up to 28% by weight [2]. While Aspergillus GA generally contains only mannose. 
glucose, galactose and in some cases xylose and glucosajnine. Rhizopus GA contains only 
mannose and glucosamine. The carbohydrate-peptide linkages are primarily 0-glycosidic 
linkages, involving the hydroxyl group of L-threonine and L-serine residues: N-glycosidic 
linkages involving L-asparagine have also been identified. A cluster of four to seven O-
linked carbohydrate moieties is a unique characteristics of .4. niger G.A.. These sugars 
do not play an importajit role in enzyme activity but they do contribute to protein sta­
bility [3,4]. The molecular masses of glucoamylases vary from 20.000 to 306.000 Da [2]. 
Usually no subunit structure has been reported with the exception of glucoamylase from 
Diazyme and 5. diastaticus [5.6]. While the molecular mass of GA from .4. awamori var. 
kawachi HF-15 is 250.000 Da, most of the Aspergillus species produce GA with molec-
ulcir masses ranging between 60,000 and 102,000 Da [2]. The pH of optimum catalysis 
varies from 3.5 to 7.0 for GAs from Aspergillus. Rhizopus and Saccharomyces species [2]. 
and isoelectric points vary between pH 3.9 and 5.5 [1]. 
Multiplicity 
The fungal glucoamylases occur frequently in multiple forms. In general the multi­
plicity of glucoamylases. though species specific, can be explained by the action of pro­
teases, present in the culture, on parent glucoamylase molecules. However, other mech­
anisms such as differential splicing of mRNA transcribed from one glucoamylase gene 
and stepwise degradation of a parent glucoamylase by endogenous protease(s) can not 
be excluded. Hayashida found three forms of glucoamylase in submerged cultures of A. 
awamori Veir. kawachi and arbitrarily designated these glucoamylases as glucoamylase-
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I. -I' and -II with molecular masses of 90.000. 83.000 and 62.000 Da. respectively [S|. 
Later. Hayashida et al. showed that multiple forms of glucoamylases were the result of 
stepwise degradation of native glucoamylase by fungal acid proteases and glycosidases 
present during fungal cultivation and enzyme purification [9.10]. This finding Wcis further 
supported when Hayashida and Flor obtained one form of glucoamylase produced from 
a protease-negative. glycosidzise-negative mutant of .4. awamori var. kawachi [II]. Ono 
et al. isolated six forms of GA from a commercial preparation of .4. niger [12]. These 
GAs have different molecular weights, pi and kinetic parameters [13]. However. Pazur et 
al. chromatographically isolated and purified two forms of A. niger glucoamylase with 
molecular mcisses of 99000 and 112000 Da [14]. In 1982, Svensson and her colleagues 
purified two forms of .4. niger glucoamylase. obtained from commercial preparation. 
She designated these enzyme forms as GI and Gil [7]. Boel and his colleagues reported 
that both GI and GII were the products of two mRNAs. which originated from the 
differential splicing of the primary mRNA transcript [15]. However. Svensson et al. pro­
posed that GII might be generated by limited proteolysis of GI [16]. These two variants 
of glucoamylcise have identical N-terminal sequences and have indistinguishable kinetic 
parameters for maitooligosaccharide substrates. However, GII differs from GI by the 
absence of the C-terminaJ portion of 104 amino acid residues. 
Coutinho and Reilly assigned five-subfamilies, Aspergillus, Rhizopus. Saccharomy-
copsis, Saccharomyces and Clostridium, based on hydrophobic cluster analysis of GA 
sequences [17]. The results of this cinalysis also indicate that all known amino acid se­
quences of glucoamylase axe similax. The complete amino acid sequence of A. niger 
glucoamylase has been obtained [18] and its sequence is identical to that from A. 
awamori [19]. The crystallographic studies reported in this thesis have focused on the 
catalytic domain, consisting approximately of residues 1-470 of A. awamori glucocimy-
lase. The amino acid sequence up to residue 471 of the catalytic domain of A. awamori 
variant XlOO , the crystal structure of which had been determined in the Honzatko 
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laboratory [20]. varies in twenty four positions when its sequence is aligned with the .4. 
niger/A. awamori GA sequence: twenty- three amino acid replacements and one amino 
acid deletion. 
Cloning of Glucoamylase 
There has been longstanding interest in cloning and expressing the glucoamylase 
genes in S. cerevisiaeihaker's yeast): it is easy to genetically manipulate the recombi­
nant glucoamylase gene in yeast; a yeast strain containing glucoamylcise cDN.A would 
convert staxch into ethanol for the industrial production of alcohol; yezist properly han­
dles post-translationai processing by checking the leader sequence at the endoplasmic 
reticulum, followed by proteolysis with the dibasic KEX2 proteinase within the golgi: se­
creted enzyme is glycosylated at levels comparable to those of the native fungal enzyme: 
S. cerevisiae is generally regarded as safe; yeast transforments containing recombinant 
plasmid(s) are able to grow on minimal media containing e.g.. ammonium sulfate for the 
production of labeled protein that caji be used in multidimensional NMR experiments; 
screening of thermosensitive glucoamylase mutants on starch plates can be done easily by 
measuring the diameter of the clearing zone around the growth area. In 1985. Innis et al. 
reported the cloning of A. awamori glucoamylase cDNA in an autonomous replicating 
plasmid using an enolase promoter and terminator. Yeast transforments harboring the 
plasmid efficiently secreted glucoamylase into the medium. Glucoamylase thus obtained 
was glycosylated, correctly processed and enzymatically active [21). In the same year, 
Ashikari and his colleague reported the cloning and expression of Rhizopus glucoamylase 
in 5. cerevisiae [22]. Several non-Saccharomyces species also exhibit the potential for 
serving as excellent hosts. Methylotrophic yeast of Hansenula polymorpha will produce 
glucoamylase of Schwanniomyces occidentalis [23]. Fungi have also served as hosts for 
glucoamylase production. Glucoamylase of Aspergillus shiroxisami hcis been expressed 
in .4. oryzat. resulting in an improved .4. oryzae fermentation strain [24]. Prokaryotic 
organisms such as Escherichia coti have been used to express glucoamylase of Saccha-
romycopsis fibuligera origin [3]. .Although protein expressed in bacteria is deposited in 
inclusion bodies, in vitro renaturation from inclusion bodies yielded non-glycosylated. 
active glucoamylase. 
Industrial Use 
Glucoamylase is a very important industrial enzyme, being second in worldwide dis­
tribution and sales among industrial enzymes [25]. The enzyme has been used worldwide 
in the starch processing industries. /I. oryzae is the most important fungus in Japanese 
food and beverage industries, being used for sake (Japanese rice wine), shoyu (soy sauce) 
and miso (soy bean paste). Starch, composed of ajnylose and amylopectin. is the prin­
cipal raw material for beer, maltose syrups, high glucose syrups of DE 95-96. and high 
conversion syrups of DE 60-70 and ethanol. Dextrose equivalent, DE. is an indication 
of total reducing sugar content expressed as apparent glucose on a percent dry weight 
basis. 
Although detailed protocols for the production of high glucose syrups of DE 60-
70 vary, syrup production is basically a two-step process. The first step, known as 
liquefaction of starch, involves dispersion of staxch granules into aqueous solution. Then 
the aqueous slurry of starch is hydrolyzed either by acid or by a bacterial thermostable 
Q-amylase at pH 6.0-6.5. The treatment involves cooking the starch slurry at 105°-140°C 
for five minutes followed by dextrinization around 95°C for approximately two hours. 
This results in a mixtures of dextrins that consists mixture of mziltooligosacchaxides, 
with a concomitajit decrease in viscosity, which facilitates subsequent processing. The 
second step is a sacchzurification process, where liquefied staxch is treated either with a 
mixture of /3-amyl2ise and glucoamylase at 55°C, pH 5.0-5.5, for 48-72 hours to produce 
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high conversion syrups of DE 60-70 or with glucoamylase alone at 60°C. pH 4.0-4.5. 
for 4S hours to produce glucose syrups of DE 95-96. The high glucose syrups are used 
for the production of crystalline D -glucose or as a starting n:iaterial to produce high D 
-fructose syrups with immobilized glucose isomerase at pH 7.0-S.5 and 60°-65°C. 
Glucoamylcise hcis also been used widely in the fermentation industries for ethanol 
production. The conventional fermentation process for the conversion of starch to 
ethanol requires cooking of the starch over 140°C for liquefaction and then sacchari­
fying with glucoamylase to produce fermentable sugars (described earlier). These sugars 
are readily fermented to ethanol by yeast. Saccharomyces species, among which 5. cere-
visiae var. diastaticus is notable for its ability to secrete GA extracellularly and ferment 
starch. However, the liquefaction and sacchaxification take 30-40% of the total energy 
spent for ethanol production [27]. In order to save energy consumed during liquefaction 
and sacchaxification. a noncooking method for alcoholic fermentation has been adopted 
in Japan and Brazil [26.28]. This method combines liquefaction, saccharification and 
yeast fermentation in a single step for alcohol production from raw starch without cook­
ing and autoclaving. and the method has been used successfully to produce ethanol 
from sweet potato, ceissava root and maize [26-28]. Another way to combat the high 
energy cost is to construct S. cerevisiae strains, which have high fermentation rates and 
ethanol tolerance, to co-express and secrete o-amylase and glucoamylase [29]. Shibuya 
et al. fused a-amylase and glucoamylase cDNAs of .4. shirousamii and expressed the 
fused gene in 5. cerevisiae. from which the bifunctional protein weis secreted into the 
medium [30]. The fusion protein showed enzyme activities chaxacteristic of Q-amylase 
and glucoamylase. There have been more reports on the successful production of q-
amylase and glucoamylase as a fusion protein [31.32]. 
Thermosensitive glucoaxnylcise plays an important role for the production of low-
carbohydrate or low-calorie beer production. Raw material for beer production (called 
wort) contains glucose, sucrose, fructose, maltose, maJtotriose and larger maitodextrins. 
Brewers yezist can ferment wort carbohydrates, leaving the larger dextrins unfermented. 
Addition of glucoamylase would hydrolyze dextrins into glucose that can be readily 
used by yeast for the fermentation production of ethanol. However, if glucoamylase 
is not inactivated by pasteurization, then the residual dextrin would be converted to 
glucose in the beer container within a few weeks by glucoamylase. making beer sweet. 
Thermosensative glucoamylcise, e.g. GA from 5. occidentalis. can be inactivated during 
the pasteurization step, thereby avoiding the sweetening of beer upon storage [33]. 
Glucoamylases produced by organisms satisfy the needs of that organism. However, 
natural GAs do not entirely satisfy the demands of the harsh industrial conditions used 
in starch processing. GAs exhibit a number of limitations. For example, a long digestion 
time for saccharification results in a mixture of glucose and reversion products, which 
prevents complete conversion of stajch into glucose. .Although reversion products from a 
number of enzymes have been reported since 1889. Watanabe in 1969 characterized the 
reversion products as nigerose, maltose, isomaltose. isomaltotriose. panose and isopanose 
from R. niveus G.A. incubated with 40% d-glucose at 55°C for 96 hours [34]. Since then 
a number of kinetic models, which account for the synthesis of reversion products, have 
appeared in the literature [35-38]. The second problem in industrial utilization of G.'\ 
is its pH of optimum catalysis (4.5). which is relatively low compared to o-amylcise and 
glucose isomerase. enzymes used in conjunction with GA in starch processing. As a 
result, the pH of the digestion reaction has to be adjusted, leading to the formation of 
undesired inorganic salts that must be removed. On an industrial scale this is an expen­
sive process, particularly if one considers the operation of ion-exchajige chromatography 
to remove salts. The third limitation is that glucoajnylase is unstable above tempera­
tures of 60°C. As a result, saccharification is done at low temperature and in digestion 
mixtures of high viscosity, which maJces the glucoamylase digestion of oligasaccharadies 
the rate limiting step in glucose syrup production. 
s 
Enzymology 
Glucoamylase acts on number of substrates like starches, glycogen, isomaltose. dex­
trin. panose, oligo-. di- and polysaccharides. Although starch is the primary substrate 
for GA in the starch processing industries, in the research laboratory pure substrates 
are used to understand the structure/function relationship of GA. as molecular size 
and structure of the substrate play an important role in determining the enzymic rates 
of hydrolysis. The action of .4. niger glucoamylase on oligosaccharides labelled at the 
nonreducing end with C'"* demonstrated that the initiai attack of the enzyme results in 
the liberation of glucose from the nonreducing end of the oligosaccharide molecule [39]. 
The enzyme is capable of hydrolyzing q-(1—>4), q-(1->3) and q-(1—>'6)-bonds [40.41]. In 
general, the hydrolysis rate of oligosaccharides is dependent on the next bond in the se­
quence and the molecular weight of the substrate, e.g.. the catalytic efficiency [kcat 11^ m ) 
for the Q-(l->4)-bond (maitose substrate) is 420-fold higher than that of a-(l—>6)-bond 
(isomaltose substrate) and for that of linear substrate maltose and maltoheptose is 56-
fold higher, where the kinetics parameters have been determined at 45°C and pH 4.5 [42]. 
In amylase and lysozyme catalyzed hydrolysis of linear oligosaccharides, the kcat/ 
varies as a function of degree of polymerization (DP) of the substrates. In 1970, Hiromi 
proposed a subsite theory for glucoamylase to explain DP-dependencies of kinetic pa­
rameters [43]. The theory assumes important non-productive binding of the substrates 
and an intrinsic catalytic constant independent of substrate length. .According to the 
theory glucoamylase has five to seven subsites, cleavage occurs at the glycosidic bond 
between glycosyl moieties located at subsite 1 and 2, subsite 2 has the most negative free 
energy of binding between substrate and enzyme, the free energy of binding decreases 
from subsite 3 to subsite 7 and the free energy of binding for subsite 1 is very low. The 
subsite theory has provided estimate of the free energies of binding for glucoamylase en­
zymes obtained from different species, and it has been shown that ail the glucoamylases 
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have active sites of six to seven subsites [44-47]. 
The active site of glucoamylase hcis been studied over Icist 30 years. Hiromi and 
his colleagues conducted studies in the kinetics of glucoamylase cis a function of pH 
(2.2 to 6.9). using substrates maltose [q-d-(1—>-4)bond] and panose [q-d-(1—>4) q-
D-(1—>^6)bonds] [48]. They showed that the same ionizable groups, carboxylates with 
pKa 2.9 and 5.9. are involved in the catalysis of both substrates. This finding has been 
further substantiated by Savel'ev and Firsov [49]. In 1990. Svensson et al. identified 
the acarbose-protected acidic residues Aspl76. Glul79 and GlulSO [50]. These residues 
are likely to be of functioned significance, as they mapped onto one of the sequence-
conserved regions [51]. To determine whether these acidic residues were involved in 
catalysis, Sierks et al. constructed the following mutajits. Aspl76Asn, GluI79Gln and 
GlulSOGln [52]. Kinetic studies of the above mutants implicated Glu as the general acid 
catalyst with a pKa of 5.9. Crystailographic results are consistent with Glul79 eis an 
acid catalyst [61]. The base catalyst. Glu400, of GA has been identified from crystal the 
structure of glucoamylase complexed with the glucose analog 1-deoxynojirimycin [59]. 
Directed mutation of Glu400Gln confirmed that Glu400 serves as a catalytic baise [42]. 
A molecular mechanism for the glucoamylase-catalyzed hydrolysis reaction has been 
proposed. Fleetwood and Weigel conducted hydrolysis of maltose by glucoamylase in 
H2®0 and concluded that maltose hydrolysis proceeds by the fission of the bond between 
the anomeric carbon and glycosidic oxygen atoms [60]. A number of years later Svens­
son and her colleagues proposed the following model on the basis of crystallography 
ajid enzymology. Glucoamylase-catalyzed hydrolysis of oligosaccharides involves proton 
donation from catalytic acid Glul79 to the glycosidic oxygen of the substrate. This 
results in an oxoctirbomum ion intermediate and deprotonated Glul79. Electrostatic 
interaction through negatively charged Glul79 would stabilize the oxoccirbonium ion in­
termediate. Catalytic water 500, polarized by Glu400, is added at C-1 of oxocarbonium 
ion, resulting in the /3-d-glucose product [42]. 
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Kinetic studies of R. niveus: giucoamylase withi ligands (maltose and d-gluconolact 
one) suggested a two-step kinetic mechanism. The first step is a fast and weak bimoiec-
ular process, where ligands bind at subsite 2 of the enzyme. This is followed b\- a slow 
unimolecular process involving relocation of ligaiid from subsite 2 to subsite I. resulting 
in a productive enzyme-ligand complex [53]. In 1992, Olsen et al. conducted kinetics ex­
periments of .4. niger giucoamylase and interpreted similar kinetic results differently [.54] 
by arguing that free energy of binding of subsite I is 2.6 kJ/mol. whereas that of subsite 
2 is -21.4 kJ/mol [55]. .-Vccording to their model, the first step is a fast bimolecular 
process where substrate associates with equal probability either at subsite 1 or subsite 
1 and 2. This is followed by the formation of a productive enzyme-substrate complex 
with a concomitant change in enzyme conformation. The model proposed b\- Tanaka 
ajid Olsen can be represented as follows: 
ki h , 
E + G EG EG- -1^ E -I- P -Model I 
fc—1 A:_2 
where E is the enzyme. G is the substrate. EG is the initial enzyme-substrate com­
plex. and EG' is the Michaelis complex (i.e.. the productive stable intermediate), the 
breakdown of EG" intermediate i.e.. the hydrolytic step is the final rate determining 
step. 
Natarajan and Sierks have identified enzyme-substrate and enzyme-product com­
plexes by studying pre-steady-state and steady-state kinetics of the wild-type and VV120F 
GA/maltotriose in H2O and D2O [56]. Their studies suggest that GA-catalyzed hydrol­
ysis involves the following steps: 
E - h G  ^  E G  ^ EP^ E  + P Model II 
k-i k.2 
where E is enzyme, G is the substrate, EG is an enzyme-substrate complex, and EP is 
enzyme product intermediate. The first step involves the one-step process of Michealis 
complex formation. The second step represents glycosidic bond hydrolysis and formation 
of enzyme-product intermediates. Product is released in the third step, and this step is 
rate limiting. This model differs from Model I where the hydrolytic step was proposed to 
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be the rate limiting step, .'\ccoding to Model II product release is rate limiting then how-
is it possible to observe secondary isotope effects? This makes Model II questionable. 
Domain Organization 
GAI is a multidomain glycoprotein with catalytic domain (CD) at the X-terminus 
(residues 1-470) linked to a non-catalytic starch binding domain (SBD) at the C-terminus 
(residues 509-616) by a highly glycosylated linker (residues 471-508). .A preliminary .x-ray 
study of the proteolytically cleaved glucoamylase from .4. awamon variant XIOO/D27 
was reported in early 1992 [57]. Within a few months the first high resolution crystal 
structure of the CD from .4. awamori variant XlOO had been determined to 2.2-.\ [20]. 
The crystal structures of the CD have been determined at pH 4 and 6 [58]. with inhibitors 
1-deoxynojirimycin [59]. acaxbose and D -JF/uco-dihydroacarbose [61-63]. The catalytic 
domain has 13 Q-helices with antiparallel /3-loops connecting adjacent a-helices arranged 
into an (0/0)3 barrel [20]. The barrel consists of an inner core, where there exists a set 
of six mutually parallel Q-helices. These Q-helices are joined with each other through 
another set of six mutually parallel outer Q-helices, which are perpendicular to the 
set of inner helices. The a/a barrel has a funnel-shaped active site pocket, with 15 A 
diameter at the bottom and a depth of 10 A. It accommodates both malto- and isomalto-
oligosaccharide chains [20,63]. Residues 430-440 and specific side chains block one end 
of the active site pocket, while other end is open for incoming substrates and solvents. 
The last 30 C-terminal residues, most of which are O-glycosylated. wrap around part 
of the catalytic domain. There exist three pairs of disulfide bonds between residues 210 
and 213, residues 262 and 270 and residues 222 and 449. Residues Asnl71 and Asn395 
axe covaJent ly  (3-Cl  l inked to  N-glycosyl  chains  of  s imilar  conformation [58] .  The Q / Q  
barrel folding pattern is aJso observed in cellulase-D from Clostridium theTmocellum [64] 
and farnesyl transferase [65]. However, other amylolytic enzymes (Q- and /3-amylases) 
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share an a/3 barrel fold for their catalytic domain [66. 67]. Image analysis of intact 
glucoamylase. obtained by scanning tunneling microscopy, shows a dumb bell shaped 
globular protein of approximately 6 nm diameter [68]. 
Approximately 60% of the amino acid residues of the linker domain are L-threonine 
and L-serine and most of them are O-linked to mannose [109] thus providing protection 
from proteolytic cleavage to the linker domain [69]. .A model for the N-terminal half of 
the linker domain predicts an extended conformation for the polypeptide chain to relieve 
steric interactions between majinosyl groups of the linker [20.61]. Scanning tunneling 
microscopy reveals that the entire 0-glycosylated domain is rigid and extended [68.70]. 
However, the presence of two glycine repeats in the C-terminal half of the linker may 
permit some conformational flexibility. 0-glycosylated linkers are also found in hydro­
lases such as xylanase [71]. endoglucanase A [72]. and l,4-/3-d-glucan glucohydrolase 
D [73]. For glucoamylase, the linker may facilitate GA secretion [74. 7.5]. enhance raw 
starch digestion [76,77] and stabilize the SBD against thermal unfolding [78]. 
The C-terminal domain of Aspergillus G.A.S, consisting of residues 509 to 616, forms 
the starch binding domain (SBD), whereas the N-terminal portion of R. oryzae GA is 
the SBD [18]. The starch binding domain allows the enzyme to be adsorbed to the 
surface of starch granules [79,80]. Hydrolysis of starch granules, however, takes place 
at the catalytic domain of the protein. SBD-truncated glucoamylases exhibit impaired 
raw starch digestion and raw starch-binding activities [7,81]. Svensson et al. compared 
the rate of hydrolysis of raw starches such as waxy maize starch, corn starch, wheat 
starch and rice starch by glucoamylcise I ajid glucoamylase II [7]. They found that 
glucoamylase I hydrolyzes raw starch granules 20-30 times faster than glucoamylase II. 
This is presumably due to the better binding of raw starch granules to glucoamylase 
I compared with glucoamylase II. Daiamia and Nikolov characterized glucoamylase I 
and -II adsorption to raw starch from com and found that equilibrium adsorption for 
glucoamylase I to corn starch is 100-fold higher than to glucoamylase II [82]. The SBD 
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has been successfully produced in large quantities (200 mg/L) in the homologous host. 
,4. niger. [83] and its solution structure has been determined by NMR [84.85]. The 
SBD structure, an open sided /3-barrel, consists of one parallel and six antiparallel pairs 
of J-strands. This antiparallel /^-barrel is anticipated, because SBD sequences are ho­
mologous to the C-terminal putative starch binding domain (domain E) of cyclodextrin 
glycosyltraxisfercises [66|. the crystal structures of which are known [86.87], The presence 
of two /3-cyclodextrin binding sites, as shown by isothermal titration calorimetry [88]. 
are putatively located at one end of /3-barrel fold on opposite faces [85]. The SBD plays 
an important role in fungus growth. At low fungal cell concentration. SBD binds G.A to 
the fungus cell wall [89]. which results in enhanced glucose flow into the cell. At high 
fungaJ cell concentration, secretion of GA is favored into the culture medium due to 
activation of acid proteinase [90]. 
Dissertation Organization 
This dissertation is presented eis three journal papers followed by a general introduc­
tion and conclusion. Figures are listed at the end of each chapter and the references of 
each chapter are cited after the general conclusion. 
In Chapter 1, the background information about glucoamylase heis been included. 
Chapter 2 represents the production, characterization and thermal denaturation studies 
of starch binding and catalytic domain of glucoamylcise. Chapter 3 represents X-ray 
crysteJlographic studies of thermostable mutant glucoamylases. Chapter 4 describes a 
method that positively identify glycosylation sites for starch binding domain, carcinoem-
bryonic antigen peptides and a-lactaJbumin. My contribution to chapter 4 is to clone, 
prepare and purify starch binding domain. In additon, I wrote paxt of the materiais and 
method related to starch binding domain. 
14 
CHAPTER 2: PRODUCTION, CHARACTERIZATION AND 
THERMAL DENATURATION STUDIES OF THE 
CATALYTIC AND STARCH BINDING DOMAINS OF 
GLUCOAMYLASE FROM ASPERGILLUS AWAMORI 
A paper to be submitted in the Journal of Protein Engineering 
Khan, S. M. A. aoid Ford, C. 
Abstract 
Aspergillus awamori catalytic (residues 1-470) and starch binding domains (residues 
508-616) were prepared by directed mutagenesis and purified to homogeneity as judged 
by amino acid sequencing and composition anaJysis. Both sedimentation equilibrium 
experiments and MALDI-TOF spectra of GA470 and the SBD show molecular masses 
of 56.2 and 12.5 kDa, respectively, and carbohydrate contents of approximately 12% and 
5%, respectively. GC/MS studies on the SBD and its 161-162 Da mass unit difference 
in MALDI-TOF spectra indicates presence of mannose residues. The thermal unfolding 
transition for GA470 is calorimetrically irreversible at pH 7.5, whereas that of SBD 
is completely reversible at pH 6.0-8.0, as measured by circular dichroism. At pH 7.5, 
GA470 unfolds with a high degree of cooperativity, producing a single sharp aisymmetric 
endotherm in DSC with Tm of 60.9°C and AH of 410 kcaJ/mol. In contrast, at the same 
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pH, thermal transition of the SBD occurs at 5I.3°C with a AH of 71 kcal/mol. Analysis 
of DSC scan rate dependency data suggest that the thermal unfolding of GA470 was 
partially under kinetic control and did not follow a simple two-state irreversible model. 
Comparison of of isolated ajid intact SBD and GA470 indicates that the catalytic 
domain/linker thermally stabilizes the binding domain by at least 5°C. Solvent accessible 
surface area calculations along with experimentally determined AH values indicate that 
glycosylation affects AH ELS much as 59 kcal/mol for GA470 and 13 kcal/mol for SBD. 
Introduction 
Aspergillus au/amorz glucoaxnylase I (GA I; L4a;-D-glucan glucohydrolase. EC 3.2.1.3) 
is an exo-acting carbohydreise that cataJyzes the releeise of B-o -glucose from the non-
reducing ends of starch and other polysaccharides [39j. GA I is a multidomain glyco­
protein with the catalytic domain at the N-terminus (residues 1-470) linked to a non-
catalytic starch binding domain (SBD) at the C-terminus (residues 509-616) by a highly 
glycosylated linker (residues 471-508). The N-terminal domain of A. awamori variant 
XlOO contains residues Glul79 and Glu400. which are responsible for catalysis, whereais 
the C-terminal domain allows glucoamylase to be adsorbed onto the surface of starch 
granules [52,59,82]. The catalytic domain of A. awamori variant XlOO has been pre­
pared by proteolytic action of subtilisin and purified chromatographically [91]. A high 
resolution crystal structure of the catalytic domain from A. awamori variant XlOO hcis 
been determined [20]. Recently the starch binding domain has been produced in .4. 
niger and its solution structure has been determined by NMR [84, 85]. 
Although the two-domain architecture of GAI has clearly been observed, temper­
ature denaturation experiments by DSC of the entire enzyme showed only one broad 
endotherm [78,92]. This is because unfolding transition temperatures of the two domains 
are within approximately 5°C of each other and heat absorbed from the C-terminal do­
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main is approximately one-seventh of the total heat absorbed by the entire molecule. 
For example. DSC studies on native A. niger glucoamylase showed an endotherm at 
62°C with AH of 604 kccd/mol. Up on rescanning the first run. an endotherm of 
at 58°C. AH of 72 kcal/mol has been observed and attributed to the starch binding 
domain [92]. Although heat induced unfolding of the C-terminal starch binding domain 
is reversible, the N-terminus of the enzyme unfolds irreversibly. Despite the apparent 
irreversibility of the large N-terminal domain of GAI. Tanaka et al. analyzed DSC data 
by fixing AHca//AH„/Ho unity and deconvoluting the DSC curve into five overlapping 
transitions that were attributed to the unfolding of the two domains of the protein [92]. 
The fact that the transition of N-terminal domain is irreversible does not necessarily 
present a problem in the application of DSC. The only requirement of DSC is the ex­
istence of a chemical equilibrium throughout the temperature range of the transition. 
Therefore, an analysis of the unfolding behavior must include a detailed study of the 
dependency of caJorimetric traces on scan rate, in order to confirm whether equilibrium 
thermodynamics can be applied to analyze DSC data [93]. 
No systematic thermal denaturation studies on isolated domains of G.A. are available. 
Such studies would provide information regarding domain energetics and effects of glyco-
sylation on the stability of isolated domains, and in conjunction with studies of the intact 
protein, they provide information on cooperative interactions between the domains in the 
context of the intact protein. In light of these above issues, we have employed directed 
mutagenesis techniques for producing polypeptide fragments that correspond to the cat­
alytic ajid starch binding domains and have studied them by DSC and CD. In addition 
to temperature denaturation studies, we also report here a biochemical characterization 
of these domains. 
^AHco/. calorimetric enthalpy obtained from the area under the excess Cp curve k. AHu/, van't Hoff 
enthzdpy. 
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Materials and Method 
Materials: All restriction enzymes and the pGEM7Zf( + ) plztsmid were obtained from 
Promega. Madison. WI. Saccharomyces cerevisiae strain C468 (MATa. leu2-3. Ieu2-ir2. 
his3-ll. his3-I5. mal~) [21] and .4. atcamon" glucoamyleise expression/secret ion vehicle. 
YEpPMlS [94]. were gifts from Cetus Corporation, Emeryville. C.A.. Acarbose was a 
gift from Miles Laboratories. Elkhart. IN. Bovine serum albumin, glucose, histidine. hy-
droxylamine. lysozyme, sodium acetate, sodium chloride, sodium phosphate, trisodium 
phosphate monobasic, trifluroacetic acid were from Sigma Chemical Co.. St. Louis. 
MO. Enterokinase was from Biozyme Laboratories International Ltd., San Dieog. C.A.. 
Sinapinic acid and acetonitrile were from Aldrich.. Milwaukee. WI. Centraprep filters 
(3 and 30 kDa molecular weight cut off) were from Amicon Inc.. Beverly. M.\. Dialysis 
membrane were from Spectrum, TX. SD + His minimal medial contains 0.67% yeast 
nitrogen base (DIFCO, Detroit, MI), 2% glucose and 20 /ig/ml histidine. 
Methods: Construction of Mutant Genes: An existing pGEM7Zf( + ) plasmid. con­
taining a 3.9 kb Xho l-EcoR I fragment from YEppmlS encoding the entire wild type 
.4. awamori glucoamylase cDNA. was utilized. An in vitro mutagenesis kit. Muta-
Gene^^^. from Bio-Rad (Bio-Rad Laboratories, Beverly, CA) was used to perform 
site directed mutagenesis based on a method developed by Kunkel [95]. Synthetic 
oligonucleotide primers were synthesized at the Nucleic Acid Facility at Iowa State 
University. The oligonucleotide used to transform A471 into a stop codon was 5'-
CGAGTATCGTAG.ACTGGCGGC-3', where bold face letters represent the altered 
codon. For the production of SBD, an adapter (5'-CTAGTGATGACGATGACAAGG-3' 
and 5'-CTAGCCTTGTCATCGTCATCA-3') containing the enterokinase (EK) cleavage 
site wcis introduced at the unique Nhe I site of the GA gene in pGEM7Zf(+). The engi­
neered EK cleavage site, DDDDK, was inserted between T496 and A497. Directed muta­
genesis, using the protocol above and the primer (5'-GACGATGACAAGTCCTGTACCA 
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CTCCC-3'). was used to delete residues from A49T to T507. The mutations were con­
firmed by DNA sequencing at Iowa State University (Ames. lA). A 2.3 kb fragment 
containing the mutated GA cDNA was released by digestion with Xho I and Hind III 
restriction enzymes. The isolated 2.3 kb fragment was spliced into a modified version of 
YEpPMlS. from which the wild type GA gene had been removed by digestion with Xho 
I and Hind III restriction enzymes. 
Transformation and Selection: The yeeist expression/secretion vehicle YEpPMlS con­
taining mutated GA cDNA was transformed into the yeast strain C46S by electroporation 
described in the Invitrogen electroporation manual (Invitrogen. Carlsbad. C.A.). .A.fter 4 
to 5 days of growth at 37°C, C468:YEpPM18 transforments were selected by their ability 
to grow on SD + His minimal medium that did not contain leucine. 
Production and Purification of Mutant GAs: Single isolated colonies were transferred 
to 50 ml SD + His medium and grown for about 24 hours at 30° C at 140 r.p.m. in an 
orbitaJ shaker. This culture was used to inoculate 500 ml of fresh SD + His medium 
and was grown as before. 50 ml of the latter culture was used to inoculate 21 SD + 
His medium in a 51 shake flask and fermented as before for 5 to 6 days without pH 
control. Cultured medium was at centrifuged 3840*g for 10 minutes, concentrated 20-
fold with 3x100 ml of O.IM NaOAc buffer, pH 4.5, in 0.5M NaCl by a 30 kDa molecular 
weight cut off Amicon Sl spiral ultrafiltration cartridge (Amicon Inc.. Beverly, MA). 
The concentrate was passed through a pre-equilibrated 10-mm i,d. x64-mm long affinity 
column, containing approximately 6 ml of acarbose-linked Pharmacia 616B-Sepharose 
gel, at a flow rate of 0.4 ml/min. After wzishing the column with approximately 50 ml 
sodium acetate buffer, GA was eluted by 1,7M Tris.HCl buffer, pH 7.6. The eluent was 
dialyzed against deionized water at 4°C for three days. Dialyzed protein solution was 
pressure concentrated (Amicon 30 kDa molecular weight cut off). Concentrated sample 
was either used immediately or lyophilized and stored at -70°C in a desiccator. 
Purification of SBD: Glucoamylase containing the enterokinase site was digested with 
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enterokinase according to tiie manufacturer's specification (Biozyme Laboratories Inter­
national. CA). A preparative gel filtration column was prepared by pouring polyacry-
lamide Bio-Gel P-30 (Bio-Rad Laboratories, Hercules. CA) into a 1.8x120 cm column. 
The column was equilibrated against a solution of 50mM NaOAc. pH 4.5 and O.lM 
NaCl. Enterokincise-digested protein was passed through the column at a rate of 0.1 
ml/min. Eluent was monitored by absorbance at 280 nm. The pooled SBD fraction was 
concentrated and dialyzed by filter centrifugation (3 kDa molecular weight cut off). 
Matrix Assisted Laser DesoTption Time-of-Flight Mass Spectroscopy (MALDI-TOF): 
This work was carried out on a Finnegan MAT. Lasermat 2000 (Paradise. Hemel Hem-
stead. UK). Sample is ionized by a nitrogen laser (357 nm) with a repetition rate of 1 
Hz. The matrix was 10 mg/ml 3,5-dimethoxy-4-hydroxy cinnamic acid (sinapinic acid) 
in 70% acetonitrile-30% water-0.1% trifluoroacetic acid. Salt free protein solution (0.5 
/il), dissolved in deionized water at 2-10 pmol//il, was spotted with an equal volume of 
matrix solution. .After mixing the samples were air dried at room temperature. Mass 
spectra represent the accumulation of data from 50 laser shots and were mass calibrated 
using lysozyme Mr 14307 and bovine serum albumin Mr 66430. Mciss assignment and 
data reduction wcis employed Finnegan software (Version 1.3). 
Amino Acid Composition, iV- and C- Terminal Sequencing: Amino acid composition 
cinalysis was performed at the University of Iowa Protein Structure Facility (Iowa City. 
lA). Approximately 1.7nmol of the purified sample was digested with 6N HCl contain­
ing 1% phenol at 110°C for 24 hours. For cysteine and methionine quantification, the 
sample was subjected to performic acid oxidation using freshly prepared performic acid, 
followed by HCl hydrolysis as described above. Tryptophan quantification was achieved 
by hydrolyzing the sample with 4N methanesulfonic acid where the hydrolysis condition 
is the same as the HCl hydrolysis procedure. A Beckman 6300 high-performance ion-
exchange anaiyzer was used to analyze each sample. The separation was done using a 
12 cm hydrolysate column, zmd a sodium citrate eluent in combination with a three step 
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temperature program. The system uses color-forming ninhydrin reaction with amino 
acids. The intensity of the color is proportionai to the concentration of amino acid. 
For each set of 8 to 10 samples hydrolyzed. 2 or 3 standard containing a mixture of 
all amino acids plus the internal standard norleucine, were also analyzed to calibrate 
the instrument and to permit a a quantitative determinations of the amino acids. X-
terminal sequencing of SBD was performed at the Iowa State University Protein Facility 
(.A.mes. LA.). The cysteine residues present in the SBD were modified by 4-vinylpyridine 
according to Fulmer [96]. Approximately 5nmol of vinyl pyridylethylated sample was 
placed onto a sodium dodecyl sulfate polyacrylamide gel (0.1% 805-12% P.\GE) and 
then was electroblotted onto the polyvinilidine fluoride membrane (Bio-Rad Laborities. 
Hercules. CA). N-terminus sequencing followed the protocol of Pher Edman. stan­
dard mixture of 20 PTH-amino acids were used to identify the amino acid from a Edman 
degradation cycle. An Applied Biosystem model 477A protein sequencer and a r20.A 
PTH amino acid analyzer were used. C-terminal sequencing of wild type GA470 was 
done at the Beckman Research Institute of the City of Hope (Duarte. CA) using an auto­
mated HP G1009A C-terminal protein sequencing system (Hewlett Packard. Palo Alto. 
CA) following published protocols [97]. Briefly, after applying approximately Inmol of 
sample on a Zitex membrane, the sample was reacted with coupling reagent, diphenyl 
phosphoroisothiocyanatidate, to generate peptidylacylisothiocyanate. which in presence 
of pyridine forms carboxy-terminal cyclic peptidylthiohydantoin. The latter compound 
was cleaved by trimethylsilanolate to give free thiohydajitoin amino acid and analyzed 
on axi HP reversed-phase PTH analytical HPLC column. The thiohydantoin-amino acid 
mixture was used as a standard. 
Gas Chromatography and Mass Spectroscopy. This work was performed at the Uni­
versity of Georgia Complex Carbohydrate Research Center (Athens, GA). Approxi­
mately 250 iJ.g of SBD was analyzed for monosaccharide composition by prepEiring 
the trimethylsilyl (TMS) derivatives of the methyl glycosides, followed by gas chro-
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matography and combined gas chromatography/mciss spectroscopy (GC/MC) analysis. 
TMS methy glycosides were prepared from the samples by methanolysis in IM HCl in 
methanol at 80°C for 16 hours, followed by N-acetylation with pyridine and acetic anhy­
dride (for detection of amino sugars) for 20 minutes at 100°C. The resulting methylgly-
cosides were then derivatized with the trimethylsilane reagent, Tri-Sil (Pierce Chemical 
Co., Rockford. IL). These procedures were accomplished as previously described [98.99]. 
GC/MS cinalysis of the TMS methyl glycosides was done on an HP 5890 GC coupled to 
a 5970 MSD using an SP2330 fused silica capillary column. Inositol wcis added to the 
sample before derivatization as an internal standard. 
Analytical Ultracentrifugation: .A.nalyticaJ ultracentrifugation was performed using 
a Beckman Optima XL-A analytical ultracentrifuge [100]. Wild-type and mutant GA 
samples were prepared in oOmM NaOAc buffer, pH 4.5 with O.lM NaCl at concentrations 
of 1.6 to 8.5/iM, corresponding to an absorbance of 0.2 to 0.6 (280 nm, I cm cuvette). 
Samples were loaded into six-channel sector shaped cells with 120 fil buffer in the three 
reference channels and 110 /ii protein in the three scmiple channels. The centerpiece 
containing sample wjis placed into an .'\n-60 four hole titanium rotor and speeds ranging 
from 7,000 to 17.000 rpm were employed. The temperature of the rotor was held constajit 
at 20°C. Centrifugation for 12-14 hours was sufficient to attain sedimentation equilibrium 
i.e., the time when successive scans taken at different time intervals were invariant. The 
gradient of protein concentration in cell was determined by UV absorption at 280 nm 
by sixty consecutive optical scans acquired at each 0.001 cm of radial spacing. The 
partial specific volume, was caJcuIated from amino acid and average carbohydrate 
composition [101,102] using the following equation 
(1) 
^HiMi 
where n,- is the number of moles of the i"' component. M, and Ui axe the molecular mass 
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and partial specific volume of component, respectively. Equilibrium sedimentation 
data for the wild-type and mutant enzymes were analyzed using the "IDEAL 1" (briefly 
one component system) model in the Optima XL-A Data Analysis Software. Version 
2.0. to obtain the apparent molecular mass. 
Circular Dichroism (CD) Spectroscopy. CD experiments were conducted at the 
Chemistry Department of Iowa State University using a Jasco-710 spectropolarimeter. 
which is computer interfaced for automatic data collection and instrument control. Sam­
ple temperature was controlled by a PTC-348A Peltier controller. The temperature of 
the sample was monitored by an external inmiersible thermocouple, accurate to ± 0.3°C. 
that is directly inserted to the sample cuvette. SBD concentration was determined spec-
trophotometrically using a calculated extinction coeflacient of 30560 M~^cm~' [103] and 
a molecular mass of 12453 Da (determined from M.A.LDI-TOF). Samples at desired con­
centration and pH were dialyzed against 20mM sodium phosphate. Wavelength scans of 
3.9 fxM SBD samples were performed using a 5-mm path length cuvette at temperatures 
of 25°. 50°. 53°. 56°. 60° and 90°C. Samples were equilibrated at each temperature for 
five minutes using a magnetic stirrer (350 r.p.m) and the stirring wzis continued through­
out the experiment. Complete spectra consisting of an average of three scans at each 
temperature were obtained by scanning from 190 to 260 nm at a 1 nm interval. A scan 
rate of 50 nm min~^ a response time of 4 seconds per point and a bandwidth of 1 nm 
were used for the experiments. Buffer scans were made and subtracted from sample 
scans. Ellipticity is reported as the mean molax residue ellipticity, [0] (deg.cm^.dmol"^). 
Thermal denaturation of SBD was conducted by scanning continuously as the temper­
ature was varied from 25° to 90°C while monitoring the ellipticity at 227.5 nm with 0.5 
second response time and a bandwidth of I nm. After denaturation, the sample was 
immediately cooled and rescanned to check the reversibility of the sample. Thermal 
denaturation was conducted with 3.9 /iM SBD at pH 6.0, 6.5, 7.0, 7.5 and 8.0. At pH 
6.0 concentrations of SBD at 0.93, 1.9, 3.7 and 7.6 /iM and a scan rate of 1°C min~' 
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were used. Scan rate dependency experiments were performed with 1.5 SBD. pH 
6.0. at rates of 0.5. 1.0. 1.5 and 3°C min~'. Assuming that thermal denaturation of SBD 
is a two-state process and that the ACp is independent of solution conditions and the 
narrow temperature range of the transition [?, 105]. the equilibrium constant (K) of the 
thermal denaturation reaction is as follows: 
K = |} (2) 
where D and N are the denatured and native state of the protein. K is related to free 
energy difference at the midpoint of the trajisition AGm: 
AGn, = -RTlnK (3) 
The difference in Gibbs free energy depends on temperature according to 
AG„, = AHn, - TASn,. (4) 
where AHm and ASm are the enthalpy and entropy of unfolding at the midpoint of the 
thermal transition. From equations 3 and 4. 
—RTlnk = AHjn — TASm (5) 
T' —^Hm //y\ K = e RT * e R (6) 
If Yoba is observed molar ellipticity, then for the two state process the equilibrium constant 
for the reaction is 
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^ _ Vobs - (yn + ninT) 
(yd + mdT) - yobs 
where y„ and yj are y-intercepts of the native and denatured baselines, respectively, and 
m„ and mj are the slopes of the base lines. From equations 6 and 7 and substitution of 
the quantity AHTO/T,„ for ASm. the following equation is obtained 
_ (yn + mnT) + (yd + mdT){exp[AHn,/R x (l/T^, - 1/T)]} 
~ {1 +exp[AH^/R X (1/T^ - 1/T)]} 
Parameters yn, m„, y^, AH^ and T,n were determined from the data by nonlinear 
least squares [106]. Nonlinear least-squares fitting of the raw data to equation S was per­
formed using the NonLin program developed by M.L. Johnson for the version modified 
to run on the .'\pple Macintosh by Robert J. Brenstein (Robelco Software. Carbondale, 
I L ) .  
Differential Scanning Calorimetry. Recombinant GA470 (0.91 mg/mL) vfas e.xten-
sively dialyzed against 41 of lOmM sodium phosphate buffer, pH 7.5 at 4°C. Protein solu­
tion was degassed for fifteen minutes before transfer to the calorimeter. Sample pH was 
measured with an Orion digital pH meter. Protein concentration was determined spec-
trophotometrically using a calculated extinction coefficient of 112650 M~^cm~^ [103]. In 
the calculations of molar quajatities the moleculax mass used for the protein was 56182 
Da determined by MALDI-TOF. Differential scanning calorimetry (DSC) was carried 
out on a nano-DSC, model 5100 (Calorimeter Sciences Corporation. UT), with a cell 
volume of 866 under 2.87 atmospheric pressure to prevent degassing during heatings. 
Five different scan rates were used within the range of about 0.25-2°C/min. Buffer-buffer 
base lines were obtained at the same scajining rates. After subtraction of the buffer base 
line, the transitions were corrected for the difference in heat capacity between the initial 
aaid finad states by using a sigmoidaJ curve described in CpCalc software (Calorimeter 
Sciences Corporation) to obtain Cex ^ and from it AHco; \va5 determined. In this report 
ACp values were determined by extrapolating the initial and final state of protein and 
then taking the difference between these two extrapolated lines at the T^-
Accessible Surface Area Calculation: The solvent accessible surface area. ASA. was 
calculated based on Lee and Richards algorithm as implemented in the program ACCESS 
by Presnell [107] with a I.4-A probe radius and a slice width of 0.25-A [108]. The .-XSA 
of the unfolded state is modeled as the sum of extended Ala-X-Ala tripeptides. Changes 
in accessible surface, AASA (buried surface area), are the difference in .A.SA of unfolded 
and folded state as determined from the crystal structure. For these calculations, the 
crystaJ structure of the catalytic domain (Aleshin <L* Honzatko. unpublished data) and 
the NMR solution structure of the SBD, PDB file IKUM. were used. 
Results 
Characterization of Recombinant SBD and GA 470: The first sixteen amino acid 
residues of the SBD were sequenced by EdmJin chemistry. Threonine at position 511 
and 513 could not be identified unambiguously. The blank cycle for T511 and an unusual 
retention time for cycle six corresponding to T513 was observed. Both of these threonines 
axe potential sites of 0-glycosylation [109] ajid a blank cycle and/or an unusual retention 
time have been observed previously for the SBD [84]. Other than T511 and T513. the 
rest of the sequence is identical to that of the published sequence, including C509, which 
was modified with 4-vinylpyridine prior to Edman degradation. The N-terminal sequence 
of SBD confirms that enterokinase cleaved immediately after the introduced DDDDK 
site only. We have performed amino acid composition analysis in three separate reaction 
vials in order to determine labile Trp, Cys and Met residues in addition to other residues 
present in the SBD and GA470. Excellent agreement between determined and expected 
excess heat capacity 
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composition was found (Table 1). Gin and Asn were converted during acid hydrolysis to 
their corresponding carboxylic acids, being reported as sum of Glx and Asx. respectively. 
.Approximately 1 nmol of G.A.470 was applied to a Zitex reaction membrane and 
subjected to C-terminal sequence analysis. The first two cycles of C-terminal sequence 
analysis resulted in the identification of Val(V) cycle-1. ne(l) cycle-2. confirming that 
the amber codon at site 471 is effective in terminating polypeptide synthesis. .-Kfter cycle 
2 we observed an incresised background of thiohydantoin, presumably due to internal 
cleavage of the peptide and. therefore, we were unable to unambiguously identify residues 
beyond cycle-2 [97]. 
The glycosyl composition analysis of the SBD was done by GC/MS. The monosaccha­
rides are identified by their retention times relative to standards, and the carbohydrate 
character of these axe authenticated by their mass spectra. For interpreting the mass 
spectral data, fragment ions 73 and 204 are cheuracteristic base fragments for all TMS 
methyl glycosides and neutral sugars. When a portion of the sample was subjected to 
combined GC/MS, an ionized fragment for neutral sugar, m/z=204. was observed. The 
glycosyl composition analysis shows that SBD contains only majinose residues and the 
percentage of mannose in the sample is approximately 5% (w/w). 
Purified SBD and GA470 were analyzed by MALDI, and both samples show complex 
spectra due to oligosaccharide heterogeneity (Figure LA., IB). SBD shows a peak at the 
expected position for the unglycosylated protein (m/2=11898) and a mass difference 
between adjacent signals of 162 Da corresponding to hexose (glucose, mannose, galac­
tose, etc.). For GA470 an intense pezik at 56182 Da corresponding to glycoprotein was 
observed. The calculated molecular mass based on known sequence is 50473 Da and the 
mass difference of 5709 Da is due to the presence of oligosaccharide. GA470 contains 
two N-linked glycosylation sites, Asnl71 and Asn395, and at least ten 0-linked Ser and 
Thr residues [58]. 
Both SBD and GA470 were subjected to sedimentation equilibrium experiments and 
Table 1 Amino acid composition of CJA-170 and SI313 from amino acid analysis 
GA470 SBD 
Residue Expected Determination Residue Expected Determination 
Cysta 7 6.4 (lysta 2 2.03 
Asx 57 57.45 Asx 11 10.71 
Thr 39 39.08 Thr 18 18.49 
Ser 63 60.95 Ser 12 11.73 
Glx 33 32.69 Glx 10 9.42 
Pro 16 15.76 Pro 5 4.82 
Gly 35 34.42 Gly 6 6.18 
Ala 51 50.44 Ala 8 8.05 
Val 31 29.30 Val 8 8.00 
He 18 16.39 He 5 4.8 
Leu 37 38.42 Len 6 6.15 
Tyr 21 20.69 Tyr 6 5.86 
Pile 18 18.00 Phe 3 2.97 
Lys 8 8.43 iys 2 2.13 
Trj) 15 13.48 Trp 4 4.61 
Arg 15 15.29 Arg 3 3.02 
His 4 4.12 
Met 2 1.77 
lO 
- I  
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data were collected at three different protein concentrations and three different rotor 
speeds, giving a total of nine data sets for each sample. The aim was to characterize the 
solution behavior of GA470 and SBD with respect to homogeneity and self-association. 
The molecular masses of GA470 and SBD do not depend on either the rotor speed 
or the protein concentration, suggesting that both the catalytic and binding domain 
are essentiadly monomeric under the conditions tested [110]. Representative equilib­
rium centrifugation data are shown in Figure 2A and B. and Table 2 summarizes the 
molecular mass obtained from sedimentation equilibrium and MALDI-TOF. There is a 
good agreement between the molecular mass obtained from MALDI-TOF and equilib­
rium sedimentation experiments. This agreement is good considering that the partial 
specific volume was estimated from amino acid and average carbohydrate composition, 
which was determined from the N-linked and 0-linked carbohydrate structures that are 
observed in glucoamylase [111]-
Table 2 Molecular masses of SBD and GA470 
Domain Cal.Mol.Mass MALDI Ana. Ultra. %Carbchydrate 
Catalytic 50473 56182 56540 'Vrf 12 
SBD 11967 12451 12569 ~ 5 
CD Spectroscopy of SBD: The CD spectra of SBD was recorded at several tem­
peratures in the thermal transition zone (Figure 3). The thermal transitions show cin 
apparent isodichroic point ajound 215 nm, suggesting that thermal denaturation of SBD 
is probably a two-state process. We have followed ail subsequent thermal denaturations 
of the SBD by CD at 227.5 nm, which reports changes in the environment of tyrosine 
side chains [112]. We have chosen a CD signal at 227.5 nm because the magnitude of 
the signai change is maximal here between 25° and 90°C. There are six tyrosine residues 
present in SBD and we do not know which tyrosine residues contribute to the CD at 
227.5 nm. The ellipticity changes in the far-ultraviolet (227.5 nm) upon heating cire 
attributed to the loss of secondary structure. Also the shape of the CD spectrum of 
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SBD at QO^C is similar to the CD spectrum of heat induced denatured protein [113. 
114], 
W'e measured the thermal unfolding curves by CD in order to characterize the ther­
modynamics of unfolding of SBD. SBD was thermally denatured at a variety of heating 
rates in order to determine the majcimum rate at which the protein remains at thermal 
equilibrium as it unfolds. Data obtained were fit to Eq. 8. and Figure 4 shows the 
best fit of a typical CD thermal denaturation data set. Results of scan rate dependency 
experiments axe summarized in Table 3. Tm ajid AHm values are almost independent of 
heating rates. We have chosen a 1°C min~^ heating rate in all subsequent experiments. 
Table 3 AH and Tm of SBD zis a function of scan rate 
Scan Rate (°Cmin ') Tm (°C) AH (kcal/mol) 
0.5 58.42 80.3 
1.0 58.31 78.9 
1.5 58.33 83.4 
3.0 59.02 82.1 
Since both reversibility and monomolecularity axe required for analysis of the thermody­
namics of a two-state process, we have measured the thermal unfolding curve at several 
different SBD concentrations. Figure 5 shows that both Tm and AHm remain unchanged 
as a function of SBD concentration, spanning approximately an eight fold range. The 
constajit value of Tm suggests that the SBD is behaving as a monomer [115]. We have 
monitored thermal unfolding of SBD as a function of pH from 6.0 to S.O. In this pH 
range thermal unfolding of SBD is evidently reversible; however, white precipitate was 
observed at pH 8.0. The pH of the seimple did not change more than 0.08 pH units 
over the experimental temperature range. The data were fit to Eq. 8. The slope of 
AHm versus Tm, as determined by linear regression with R^=0.989, gives a ACp of 1.85 
kcai/(mol.K) (Figure 6). 
DSC of GA470: Figure 7 shows an original DSC curve for the thermal denaturation 
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of GA470 at pH 7.5 and at a scan rate of 2°C min~'. The thermogram shows a single 
peaJc with a transition temperature, T,TI, corresponding to the maximum heat capacity 
of 62.8°C and an enthalpy change. AH, of 415 kcal/mol. The thermal denaturation 
of GA470 is apparently irreversible, since no discernible endotherm was observed by 
rescanning the sample after it was immediately cooled from the first scan (solid horizontal 
line in Figure 7). The cause of the irreversible behavior is not due to protein aggregation 
or precipitation since none was observed. Similar irreversible behas'ior was found for 
other proteins [116. 117] and the kind of information that can be extracted depends on 
each particular situation [118]. A. study of the dependence of the DSC thermogram on 
the scaji rate is a prerequisite of proper data analysis [119]. 
Denaturation endotherms of GA470 (0.91 mg/ml) were obtained at five different 
scanning rates in the range of 0.25-2°C min~' (Figure 8). The temperatures of maxi­
mum heat capacity. Tm- are scan rate dependent, indicating that thermal denaturation 
of GA47G is. at least in part, under kinetic control. To determine what kind of thermo­
dynamic information can be obtciined from the calorimetric traces, we first analyzed the 
data based on a two-state irreversible process that can be represented as 
N 4 D Model I 
where N is the native state. D the unfolded state or, more probably, a final state resulting 
irreversibly from the unfolded one and k a first-order kinetic constant, which changes 
p 
with temperature according to the Arrhenius equation, k = Aexp(-j^). where A is the 
frequency factor, E the activation energy, R is the universal gas constant and T is the 
temperature in Kelvin. Sdnchez-Ruiz et al. developed the above mathematical model 
and proposed several methods for the anaiysis of calorimetric curves that show a scan 
rate dependency [93]. According to the above model k for the above two-state irreversible 
process is related to the observed calorimetric data by the equation 
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where v is the scanning rate (Kmin~^). Cp the excess heat capacity. Qt the total heat 
of the process and Q the heat evolved at a given temperature. T. Figure 9A shows the 
plot of In k versus I/T. As k is only a function of temperature. Eq. 9 should give the 
same rate constant when applied to calorimetric traces obtained at different scanning 
rates. In the present study the calculation of k at a particular temperature from DSC 
traces in Figure 9A varies by a factor of 4 to 7, suggesting that the thermal denaturation 
of GA470 does not follow a two-state irreversible model. The above kinetic model also 
predicts the dependence of heat evolved with temperature according to 
Figure 9B shows a plot of ln(lnQ^^) versus 1/T, and from such a plot the values of Tm 
can be calculated from the X-axis intercept. If 0.^.470 follows a two-state irreversible 
model, then the calculated from plot of Figure 9B should give the same Tm observed 
directly from the calorimetric profiles. However, the values of T„, calculated from such 
a plot deviate from the observed Tm by as much as 8°C. 
The above kinetic model also relates the temperature at the majcimum of the heat-
capacity curve (Tm) to the scanning rate, v, according to 
V AR ,,,, (11) 
Tl E ^ ' 
If GA470 follows two-state irreversible model I, then the plot of InsJ^ versus should 1 m ^ 
F 
result in a straight line with a slope equal to However, such a plot shows a noticeable 
curvature suggesting, that k is not a first-order rate constant for thermal unfolding of 
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GA470. A plot of In:^ versus ^ showed a curvature (Figure 9C) i.e.. an upward shift I m  ^ TO 
found in Tm when passing from slower to faster scan rate, suggesting that k is not an 
elementary rate constant. These results suggest that the thermal denaturation of G.A470 
does not follow the two-state model mentioned above. 
Discussion 
We have successfully produced and purified the catalytic domain of glucoamylase 
from A. awamori by the introduction of an amber codon at position A471. Introduction 
of a single stop codon appears to be effective in terminating polypeptide synthesis at 
.\471 as judged from amino acid composition, MALDI-TOF, equilibrium centrifugation 
and C-terminal sequencing data. The procedure developed for the catalytic domain 
production is straightforward and yielded sufficient quantities (approximately 4 mg/L 
of fermentation broth) for structure-function studies. The strategy for the production 
of a single domain may also be generally applicable to other multi-domain proteins 
eliminating the use of costly reagents ajid simplifying purification schemes. The amber 
codon was also introduced at position A461, but enzyme production was undetectable 
(data not shown) suggesting that the structural integrity of the catalytic domain depends 
on the last ten eimino acids in GA470 [120]. 
In order to release the SBD from the C-terminus of OA I, we have engineered an 
enterokinase recognition site, D4K, inserted between T496 etnd A497 in glucoamylase. 
The mutant enzyme when digested with enterokinase did not releeise the C-terminal 
peptide presumably due to the presence of glycosylated residues. We therefore removed 
ten amino acids by directed mutagenesis, eight of which were potentially 0-glycosylated, 
bringing the D4K site close to S507. This deleted mutant enzyme released the SBD 
peptide when digested with enterokinase, Jind the proteolytic cleavage of the SBD from 
the parent molecule was accurate and complete as judged from N-terminal amino acid 
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sequencing and SDS-PAGE (data not shown). 
MALDI-TOF spectra of SBD clearly indicate a molecular mass of 11697 Da from 
unglycosylated SBD and a cluster of peaks starting from m/z of 12453 with a mass in­
crement of 161-162 Da. Figure lA. The mass difference of 162 Da between neighboring 
peaks is due to the presence of mannose residues as judged from GC/MS studies, which 
clearly showed that SBD contains only mannose residues (5% w/w). Although we do 
not know which serine/threonine residues in SBD are glycosylated, the unusual retention 
time and blank cycle observed in N-terminal sequencing indicates that threonines at 511 
and 513 axe potential sites of glycosylation. The major species present in the enteroki-
nase derived SBD has three mannose residues with large amounts of Man4, Mans and 
Mane and small amounts of Mano, Mani, Manj, Manr, Mang and perhaps Mang. The 
engineered SBD produced in ^4. niger is also glycosylated with mannose, amd there too 
Mana is the most abundant species [83]. However, in A. niger SBD only Man2 and Man4 
occur in large amounts followed by small amounts of Mano, Mani, Mans and Mane [S3]. 
The catalytic domain and SBD in intact OA I have different thermal stabilities. The 
catalytic domain unfolds at 62.4°C whereas SBD unfolds at 56.2°C at pH 7.5 [92]. At 
the same pH, however, T^ of isolated catalytic and SBD domaiins are 60.9° and 51.3°C, 
respectively. A decrease of 5°C in T^ for isolated SBD indicates that it is more stable 
in the context of the intact glucoamylase than as an isolated domain. 
It can be seen in Figure 6 that Tm of the SBD decreases above pH 6.0 due to the 
positive cheirge in SBD. The dependence of T,n on pH can be used to calculate the change 
in number of protons bound to the unfolded state, nu, and the folded state, n/ [104], 
where An is the number of protons teiken up by SBD upon thermal denaturation. Using 
AH= 84 kcal/mol cind Tm= 58.5°C at pH 6.0, the An for SBD is 0.7 proton/molecule. 
An 2.303RT2 
(12) 
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There are nine Asp and eight Glu residues in SBD. The pKs of some of these residues are 
perhaps low compared with denatured state, as hcis been observed for the small globular 
protein, turkey ovomucoid third domain [121. 122]. 
The effect of carbohydrate in AH and ACp will be best understood when AH and 
ACp data of unglycosylated SBD and G.A.470 are available. In the interim, however. AH 
and ACp of unglycosylated SBD and GA470 can be calculated based on the structural 
energetics formalism of Freire and co-workers [123. 124], This formalism is bcised on the 
empirical parameterization of AH and ACp as a function of the differences in polar and 
apolar solvent accessible surface areeis (ASA). For accessible surface area calculations, 
we classified all oxygen, nitrogen and sulfur atoms as polar, while all carbon atoms are 
classified as apolar. The empirical parameters were gathered from statistical analysis 
of proteins for which structural and thermodynamics data are available, and from the 
thermodynamics of cyclic dipeptides [125]. Since most proteins unfold around 60±5°C. 
this temperature is quoted in the literature as a reference temperature and as such the 
parameters for AH calculations have been obtciined at 60°C [126]. We have used the 
Lee and Richards algorithm in conjunction with 3-D structural information to calculate 
the difference in accessible surface ares (AASA) of GA470 and SBD upon unfolding. 
The results are 49504 zind 9627 for GA470 and SBD, respectively. In addition, 
the buried surface area for AASAp^ and A.A.SAap'^for GA470 are 30160 A^ and 19336 
respectively, while that of SBD are 6049 h} and 3579 A^, respectively. Based on 
AASAp and AASAap with parameters derived for AH and ACp, we have calculated 
AH and ACp for GA470 and SBD, the results of which along with the experimentally 
determined values are shown in Table 4. A comparison of quantities in Table 4 suggest 
that calculated ACp values agree well with experimentally determined ACp. However, 
observed AH values for both glycosylated GA470 and SBD are higher thaji calculated 
^AASAp, difference in zurcessible surface area of polar atoms 
^AASAap. difference in accessible surface area of apolar atoms 
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values. It has been observed that the average error between the experimental and 
calculated values are ±9 and ±6 for ACp and AH. respectively [127. 128]. 
Enthalpy contributions in protein denaturation arise predominantly from hydrogen 
bonding and hydrophobic interaction [123]. the fundamental forces that also govern 
protein stability. Crystal structures of ,4. awamori variant XlOO glucoamylase-II(471) 
reveals N-linked glycans at .A.snl71 and 395 and ten O-linked Ser and Thr residues [58]. 
The N-linked glycans make 50 hydrophilic contacts with the protein, whereas 0-linked 
glycans make 67 contacts (Table 6 of reference 58). Most of these polar contacts are 
made either b\' direct hydrogen bonding or by bridged water molecules, perhaps sta­
bilizing glucoamylase conformation. GC/MS and MALDI-TOF reveals that the starch 
binding domain contains approximately 5% mannose. the longest chain length of which 
is three, four, five and six. in decreasing order. These mannose residues may modify 
SBD conformation either by hydrogen bonding with peptide residues and/or by inter­
actions with adjacent peptide residues [129]. Present studies indicate that the effect of 
glycosylation on AH is higher for GA470 relative to SBD. 
Table 4 DSC thermal unfolding parameters of GA470 
Predicted Experimental 
SBD ACp kcal/(mol.K) 1.79 1.89 
SBD AH kcal/mol 58.61 71.10 
GA 470 ACp kcal/(mol.K) 6.43 6.20 
GA 470 AH kcal/mol 351.4 410.1 
The difference in heat capacity between native and unfolded state, ACp, of the pro­
tein results from the hydration of polar and apolar groups that are shielded from the 
solvent and become exposed to the solvent in the unfolded state, and the disruption 
of noncovalent interactions present in the native state [130]. While the hydration term 
contributes 95% to ACp, the contribution of noncovalent interaction is very small and 
not more than 5% [125. 131]. According to our accessible surface area calculations, total 
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apolar surface areas buried for GA470 and SBD are 60.9% and 62.8%. respectively. Cal­
culated ACp agree very well with the experimentally determined ACp values, suggesting 
that the average percentage of buried apolar (or polar) surface areas are approximately 
the same both in glycosylated and unglycosylated molecules. It should be mentioned 
that no significant change in CD spectra due to deglycosylation of the entire glucoamy-
lase ha5 been observed [132]. which is taken as evidence that glycosylation does not effect 
the overall conformation of glucoamylsise. The ACp value for SBD presented here is in 
reasonable agreement with previous GdnHCl studies of the SBD from .4. niger [133]. 
There are a number of proteins that are similar in size to SBD. for example, thioredoxin 
is 108 amino acids long with one disulfide bond, while subtilisin inhibitor is 107 amino 
acids long. ACp for thioredoxin is 1.77 kcaJ/(mol.K) [134] and for subtilisin inhibitor it 
is 2.03 kcal/(mol.K) [135]. comparing favorably to that of the SBD [1.85 kcal/(mol.K)]. 
ACp on a per residue basis for SBD is 17 cal/(mol.K) which, is little higher than that 
of 14 ± 2 cal/(mol.K) per residue obtained from ten well-characterized small to medium 
size globular proteins [136]. The high ACp value for SBD may reflect the fact that the 
fraction of apolar buried residues is at least 2% higher than the average value of 59%. 
a quantity obtained from the analysis of the structure of globular proteins. .According 
to our literature survey, pepsinogen, for which the .3-D structure and thermodynamic 
peLTcLmeters are known, is a protein of 365 amino acids and three disulfide bonds [137]. 
and is close in size to GA470. ACp for pepsinogen is 5.77 kcal/(mol.K), whereas that of 
GA470 is 6.41 kcai/(mol.K). As ACp scales with the size of the protein, multiplying 470 
by the regressed quantity of 14±0.5 cal/(mol.K.res) [126], a slope of ACp versus number 
of residue plot, gives a ACp of 6.6 kcal/(mol.K) which is in reasonable agreement with 
the experimentally determined ACp value of GA470. 
Figure Legends 
Figure 1: MALDI-TOF mass spectra of (A) starch binding domain and (B) GA470. 
The spectrum is the average of 256 laser shots for SBD and 50 for GA470. 
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Figure 2: Sedimentation equilibrium centrifugation of (A) SBD and (B) GA470. 
Nonlinear fitting procedures were performed on data obtained after ~4S hours of cen­
trifugation. The solid line is the result of a fit to a single ideal sedimenting species. Top 
panel shows the difference in the fitted and experimental values eis a function of radial 
position. 
Figure 3: CD spectra of SBD recorded at temperature 25°C (•). 50°C (o). .53°C (A). 
56 °C (A). 60 °C (o) and 90°C (o). The spectra were collected at 3.9 /aM SBD in 10 
mM sodium phosphate, pH 6.0. 
Figure 4: Thermal denaturation of SBD monitored at 227.5 nm. SBD concentration 
was 3.9 /xM. pH 6.0. Solid line represents best fit to equation S. 
Figure 5: Tm (A) and AH (B) versus concentration of SBD. Thermal denaturation 
is performed in 10 mM sodium phosphate, pH 6.0, and monitored with CD at 227.5 nm. 
Figure 6: Temperature dependence of AH for SBD. Thermal denaturation was per­
formed at various pH in order to obtain data for plots of AH and T^- Solid line was 
determined by linear regression of data (regression coefficient is 0.989) and the slope of 
the line, ACp, is 1.85 kal/(mol.K). 
Figure 7: DSC curve of GA470 without buffer-buffer base line subtraction. Protein 
concentration was 0.91 mg/ml, 10 mM sodium phosphate, pH 7.5 and scanning rate was 
2°C min~^ The solid line is the rescan of the first scan. 
Figure 8: Excess heat capacity of GA470 at pH 7.5 versus temperature obtained at 
five different scan rates (from right to left): 2, 1.5, 1, 0.5 and 0.25 °C min~^ Protein 
concentration was 0.91 mg/ml for all the scan rate data except 0.25 °C min"^ where it 
was 1.2 mg/ml. 
Figure 9: (A) Arrhenius plot of k (min~') zissuming a two-state kinetic model. Scan 
rate: (•) 2°C/min, (o) 1.5°C/min, (v) l®C/min, (v) 0.5°C/min, (o) 0.25°C/min. (B) 
3S 
Plot of ln(lnQ%Q) versus 1/T. 1/T actually represents l/Tm- Symbols are the same as 
those in A. (C) Plot of ln(v/Tm) versus l/T^ (v is 0°C/min). Symbols are the same as 
in A. 
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CHAPTER 3: X-RAY CRYSTALLOGRAPHIC STUDIES OF 
THERMOSTABLE MUTANTS FROM A. AWAMORI 
GLUCOAMYLASE 
A paper to be submitted in the JournaJ of Protein Engineering 
Khan. S. M. ."V.. Aleshin. A.. Ford. C and Honzatko. R. B. 
Abstract 
The three dimensional structures of thermostable glucoamylase mutants. N20C/ 
A27C. N'20C/A27C/G137A and N20C/A27C/S30P/G137A. were determined at 2.5. 2.4 
and 2.3 A. resolution by X-ray crystallography. The engineered disulfide bond is formed 
in the enzyme when expressed protein was secreted from Saccharomyces cerevisiae . 
These mutant enzymes have essentially the same fold as wild-type enzyme but with an 
engineered right-handed disulfide bond with an estimated strain energy of ~4 kcal/mol 
and unusual average dihedral angle, X2=^93°. Crystallographic studies show that the pro­
line introduced at position 30 adopts a trans proline conformation. (p=-64°. and </' =131°. 
which occurs naturally in other polypeptides. We did observe a decrease in the thermal 
factors of the main-chain atoms of proline at site 30 (12 versus 20 .4^); however ther­
mal factors in and around the 20-27 loop, G137A and elsewhere in the mutant proteins 
were essentially the same as that of wild-type enzyme. High-resolution crystallographic 
analysis also reveals that replaced Alal37 was accommodated within helix-4, supporting 
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the empirical observation that Alal37 has a high helix forming propensity. Also the 
Alal37 CJ atom makes two favored van der Waais contacts (<4 A) with the carbonyl 
oxygens of Thrl33 and Alal34. Enzymatic thermostability appears to be correlated with 
the relative accessibility of the substituted residues and a decrease in backbone entropy 
of unfolding due to reduced backbone flexibility. Although the overall structures of the 
mutajits are very similar compared to wild-type glucoamylase. there are some local con­
formational differences as indicated from r.m.s. deviation values calculated within 6 
from the mutation site (Table 7). These studies also support the experimental findings 
that the effects of combined mutations in N20C/A27C/S30P/G137A glucoamylase are 
cumulative. 
Introduction 
The difference in free energy of folded and unfolded proteins is unexpectedly small. 
2-15 kcal/mol, because of compensating individual forces such as hydrogen bonds, hy­
drophobic interactions and van der Waals contacts. Introduction of additional stabilizing 
interactions might contribute significeintly to protein stability. Directed mutation proto­
cols permit the exchange of any ajnino acid residue. Protein stability can in principle be 
enhanced by 1) introducing disulfide bonds [138], 2) reducing the solvent-exposed non-
polar surface area [139], 3) introducing proline at the second position in certain bends 
of /?-turns [140], and 4) stabilizing helix dipoles by adding charged residues at the helix 
terminus [141]. Prospects for the rational design of proteins would also improve with a 
better understanding of the contribution of specific factors to protein stability. There 
is practical interest in the stability of glucoamylase because protein lability hampers 
saccarification above 60° C, and as a result glucoamylase digestion is the rate limiting 
step in the industrial production of glucose syrup 
Crystal structures of the catalytic domain of glucoamylase have been determined 
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at pH 4 «L' 6 [58], with inhibitors 1-deoxynojirimycin [59|. acarbose and D -gluco -
dihydroacarbose [61-63]. Extensive engineering studies have been carried out on .4. 
awamori and .4. niger glucoamyleise. which have identical amino acid sequences. Over 
eighty directed mutants have been produced to alter substrate specificity. pH rate profile 
and thermostability [142]. 
We now present crystal structures of three thermostable glucoamylase mutants. 
N20C/A27C. N20C/.'\27C/G137 and N20C/A27C/S30P/G137A. The above mutants 
are thermally more stable thaa the wild-type enzyme [143. 144]. We have subcloned the 
DNA fragment harboring these mutations into a glucoamyleise cDN.\ that has an am­
ber codon at 47L so that we could easily produce the crystallizable .\'-terminal protein 
fragment for structural studies. We would like to correlate glucoamylase thermostability 
with its three dimensional structure. 
The N-terminal crystaJlizable fragment of glucoamylase consists of 470 residues that 
contains three disulfide bonds: Cys210-Cys213. Cys262-Cys270 and Cys222-Cys449 [20]. 
In general, disulfide bonds can make substantial contributions to the stability of a folded 
protein [145-147]. This observation prompted the insertion of a new disulfide bond, 
which putatively decreases conformational chain entrop}' of the unfolded polypeptide. 
Although there are examples of enhanced protein stability due to introduction of disul­
fide bonds, three dimensional structures of only a few of these engineered proteins are 
available. The 3-D structure of the engineered disulfide bridge in glucoamylase would 
provide information regarding disulfide bond geometry, crystallographic thermal param­
eters and structural changes caused by mutation and disulfide bond formation. The 
structural data could bolster the strategy for the introduction of disulfide linkages likely 
to increase protein stability. 
Suzuki et al. observed a strong correlation between proline content and thermostabil­
ity of Bacillus 1,6-glucosidaise [148]. Based on this observation, he proposed the "proline 
rule", which states that the presence of the proline residue at the second position of 
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.i-turns or N-caps of o-helices with concomitant increase in hydrophobicity will enhance 
protein thermostability. Substitution of AlaST (the second position of a J-turn) with 
proline in T4 lysozyme enhanced thermostability by decrecising the backbone entropy of 
unfolding [149]. In giucoamylase SerSO is at the second position of a J-turn: the S30P 
mutant is thermally more stable than wild-type enzyme [144]. In order to investigate 
the structural effects of proline at site 30. we have pursued 3-D structure determinations 
of the S30P mutant in the context of N20C/A27C/S30P/G137A giucoamylase. 
The mutation G137A is in the middle of helix-4. Protein thermostability corre­
lates with an increase in the number of alanine residues in an o-helix. For exam­
ple. the Q-helical region of thermophilic ferrodoxin from Thermotoza maritima contains 
three alanine residues compared to one for its mesophilic counterpart from Desulfovibrio 
atrieanus [150]. The G4SA mutant of A-repressor [151] also enhances thermostability. 
In both thermophilic ferrodoxin and the G4SA mutant of A-repressor. the helices be­
come more rigid cind tightly packed with an increased number of hydrophobic contacts, 
making the protein resistant to denaturation at higher temperature. However, there are 
examples where Gly—^•.A.Ia mutations in o-helices destabilize the protein, for instance, 
the G240A mutant of 3-isopropylmalate dehydrogenase [152] and the G152.A. mutant of 
Fe-superoxide dismutase [153]. In order to enhance thermostability, the replaced residue 
1) should not introduce a steric clash with its neighbors. 2) should increase hydrophobic­
ity and 3) should not disrupt stabilizing interactions present in the wild-type structure. 
In consideration of the above issues, we have determined structures of G137A in the 
context of N20C/A27C/G137A and N20C/A27C/S30P/G137A giucoamylase. Finally, 
a comparison of crystal structures of multiple mutants with a related single mutant 
would permit us to evaluate the structural consequences that might result from multiple 
amino acid replacements. A mechanistic basis for protein stabilization is also discussed. 
Materials and Method 
Materials: All restriction enzymes and pGEM7Zf( + ) plasmid were obtained from 
Promega. Madison. WI. Saccharomyces cerevisiae strain C46S (MATQ. leu2-3. Ieu2-112. 
his3-ll. his3-l.5. mal~) [21] and the A. awamori glucoamylase expression/secretion ve­
hicle. YEpPMlS [94]. were gifts from Cetus Corporation. Emeryville. CA. Acarbose 
was a gift from Miles Laboratories. Elkhart. IN. 30 kDa molecular weight cut off Cen-
traprep were from Amicon Inc.. Beverly. M.'V. Dialysis membrane was from Spectrum. 
TX. Glucose, histadine. sodium chloride, sodium acetate and Tris.HCl were from Sigma 
ChemicaJ Co.. St. Louis. MO. Bicine and polyethylene glycol (6000) were from Fluka. 
Ronkonkoma. WI. SD -1- His minimal medial contains 0.67% yeeist nitrogen base (DIFCO 
Laboratories Co.. Detroit. MI). 2% glucose and 20 histidine. 
Subcloning of Thermostable Mutants in A471stop: An existing pGEM7Zf(-(-) plas­
mid, containing a YEpPMlS derived 3.9 kb Xho rm I-EcoR I fragment, part of which 
contained the entire wild type .4. awamori glucoamylase cDN.A.. was utilized. .An 
in vitro mutagenesis kit. Muta-Gene^'^^, from Bio-Rad (Bio-Rad Laboratories. Her­
cules. CA) was used to perform site directed mutagenesis based on a method devel­
oped by Kunkel [95]. The synthetic oligonucleotides primers, synthesized at the Nu­
cleic Acid Facility at Iowa State University, were used for the mutagenesis reaction 
5'-CGAGTATCGTAGACTGGCGGC-3' for A471—^stop, where the altered codon is in 
bold typeface. A fragment containing the .A471stop codon was excised by PstI and 
BamHI from pGEM7Zf(-|-), and was then ligated into a Pst I and Bam HI cleaved 
p-BIuescript II KS(II), resulting in clone 1. This intermediate clone allowed the intro­
duction of the A471stop mutation into previously constructed thermostable GA variants 
[143,144]. Clone 1, after digestion with Xho I and Pst I, was ligated with a 1.0 kb frag­
ment, liberated from pGEM7Zf(-l-), containing thermostable mutations in GA cDNA, to 
give clone 2. A 1.7 kb BamHI and Xho I fragment from clone 2 was ligated to YEpPMlS, 
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from which the 1.7 kb Xho I and Bam HI fragment had already been removed. 
Transformation and Selection: The yeast expression/secretion vehicle YEpPMlS [94] 
containing mutated GA cDNA was transformed into the yeast host strain C46S [21] by 
electroporation described in the Invitrogen electroporation manual (Invitrogen Corpora­
tion. Carlsbad. C.A.). .A.fter 3 to 4 days of growth at 30°C. C46S:YEpPMlS. transformants 
were selected by their ability to grow on SD + His minimal medium that did not contain 
leucine. 
Production and Purification of Mutant GAs: A single colony was inoculated into 50 
ml SD + His medium, grown for about 24 hours at SO'C. at 140 r.p.m. in an orbital 
shaker. This culture was used to inoculate fresh 500 ml of SD + His medium, which 
was in turn cultured as before. 50 ml of the latter culture was used to inoculate 21 SD 
+ His medium in a 51 shake flask and fermented as before for 5 to 6 days without pH 
control. Cultured medium was centrifuged 3840*^ for 10 minutes, concentrated 20-fold 
and equilibrated with 3x100 ml of O.IM NaOAc buffer, pH 4.5, in 0.5M NaCl using 10 
kDa molecular weight cutoff Amicon Si spirai ultrafiltration cartridges (Amicon Inc.. 
Beverly. CA). The concentrate was pcissed through pre-equilibrated acarbose affinity 
column (10 mm i.d. x 64-mm long, containing approximately 6 ml Pharmacia 616B-
Sepharose gel linked to acarbose) at a flow rate of 0.4 ml/min. .A,fter washing the column 
with approximately 50 ml sodium acetate bufTer. GA wcis eluted by I.7M Tris.HCl 
buffer, pH 7.6. The eluate was poured into a dialysis bag (30 kDa molecular weight 
cut off) and dialyzed against deionized water at 4°C for three days with an occasional 
change of water. Dialyzed protein solution was concentrated by centrifugal filtration 
(Amicon Centraprep, 30 kDa molecular weight cutoff). Concentrated sample was used 
immediately for crystallization. 
Matrix Assisted Laser Desorption Time-of-Flight Mass Spectroscopy : Mass spectra 
were taken from a commercially available Finnegan MAT, Lasermat 2000 (Paradise, 
Hemel Hemstead, UK). The sample was ionized with a 337 nm bezmi from a nitrogen 
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laser with a repetition rate of 1 Hz. The matrix used was 10 mg/ml 3.5-dimethoxy-4-
hydroxy cinnamic acid (sinapinic acid) in 70% acetonitrile-309^ water-0.l9f TFA. Salt 
free protein solution (0.5 /il). dissolved in deionized water at 2-10 pmol/^1. was spotted 
to the sample slide together with equal volume of matrix solution, .\fter mixing the two 
solutions, samples were air dried at room temperature. Mass spectra were collected by 
adding individual spectra obtained from 50 laser shots and were mass calibrated using 
bovine serum albumin (Mr 66430). Mass assignment and data reduction were done with 
Finnegan software version 1.3. 
Crystallization: Crystals were obtciined using the hanging drop/vapor equilibration 
method as described by McPherson [154]. Drops of 2-3 //l containing 22 mg/ml of 
mutant GA470 in a 40mM Bicine (pH S.O). 20mM NaOAc and 24% (w/v) polyethylene 
glycol 6000 were suspended over wells containing the same buffer at room temperature. 
Crystals appeared in 4-5 weeks and were either stored in 20mM Bicine buffer and 2S% 
(w/v) polyethylene glycol 6000 or used immediately for data collection. 
Data Collection and Processing: A single crystal Wcis mounted in a thin-walled glass 
capillary. Data were collected with a Siemens area detector using CuKq radiation and 
a graphic monochromator. The crystal to detector distance wcis 15 cm. The scan 
range was 0.25 per frames and each frame consisted of 0.25° rotation taken for 120 
seconds. The data were reduced using XENGEN [155]. Raw data within first 40-50 
frames were searched to find strong reflections, which were then indexed. Unit cell 
parameters were refined by the least square methods. Data from different scans were 
intergrated separately and then merged together. Table 1 summerizes the cell parameters 
and data collection statistics. 
Structure Refinement: The refinement of the structure was based on an energy func­
tion approach [156] an empirical combination of geometric and pseudo energy terms 
based on crystaJlographic data as implemented in X-PLOR [157]. The parameters of 
Eng and Huber were used [158]. A 4D-35 Silicon Graphics workstation was used for 
refinement and molecular modeling with the molecular graphics program TOM [159). 
The initial model used for the amino acid substitution was the l.S .A resolution struc­
ture of wild-type glucoamylase crystalized in Tris buffer. pH S.O. including O- and .V-
linked glycans (Aleshin .L* Honzatko. unpublished data). The amino acid substitution 
were performed using TOM and the resulting models were subsequently used for re­
finement. We used data with amplitude greater than 2(t for N20C/A27C/S30P/G137.A. 
and N20C/A27C ajid Icr for N20C/A27C/G137A. A randomly selected 7% of structure 
factor amplitudes were excluded from automated refinement and used to compute a 
free R factor (R/ree) throughout the refinement [160]. The refinement protocol involves 
the following steps; (1) A bulk solvent mask was calculated with X-PLOR (K5o;=:0.4 
electron/A^ ajid B3o/=200 A^) and the output reflection file was used in subsequent 
refinement cycles, resulting in major improvements in both R-value and free R-value. 
(2) Determination of the optimal weight (Wg) between x-ray and geometric restraints. 
(3) Preparation stage consisting of 40 cycles of Powell minimization and harmonic con­
straint was set to 20 kcal/mol.A^ in order to relieve bad contacts of the coordinates. (4) 
The slowcool protocol, starting temperature of 2000 K. cooling rate of 25 K/50 steps 
and 120 steps of Powell minimization decreases ~40% both R and free R values. (5) 
Individual isotropic B refinement was undertaken to obtain B-parameters for backbone 
and side-chain atoms for each amino acid residue. Cycle 2 involves steps 3-5 where step 
4 consists of positional refinement as implemented in X-PLOR. The resulting model was 
used to generate a 2|Fol-|Fcl map, into which minor side chain and backbone errors, 
many of which were flagged by PROCHECK, [161] were rebuilt. After repeating the 
protocol of cycle 2 several times, water molecules were automatically picked by search­
ing the [FoHFcl map for peaks greater than Sa that were between 2.3 and 3.4 A away 
from a hydrogen-bond donors or acceptors. After adding water molecules, the electron 
density of each was visually inspected by TOM, followed by positional and/or individual 
isotropic B-factor refinement. Water molecules with refined B factors greater than 60 
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were removed from the model. The water picking refinement procedure was repeated 
until no peaks stronger than 3<r were found in the |Fo|-|Fc| map. The occupancy of ail 
atoms including solvent molecules was kept at 1.0 throughout refinement. When the 
R-free value remained unchanged and the 2|Fo|-|Fc| maps did not reveal any significant 
residual density, refinement was halted. The program PROCHECK [161] was used to 
asses the quality of the model. 
Results and Discussion 
Glucoajnylase GA470 containing thermostable mutations was e.xpressed in 5. cert-
visiae using the YEpPMlS expression/secretion vehicle. .A. purification protocol of 
GA470 had been established by us to take advantage of GA470 being secreted into 
the culture media. We passed 50-60 fold concentrated and buffer-equilibrated culture 
medium through the acarbose affinity column from which the enzyme wa^ eluted with 
1.7M Tris buffer. pH 7.6. Since acaxbose binds strongly (K<f=10~^^M) [162] to the active 
site of the enzyme, we were initially concerned whether our enzyme preparation was 
contaminated with acarbose. Therefore, after collecting the first data set. we focused 
our attention on the active site of the enzyme to locate electron density which might very 
well fit the acarbose. We did not observe any electron density, either at the active site 
or elsewhere in the molecule, due to acarbose. Approximately 3-4 mg of GA470 could 
be obtained from a single liter of culture. Figure 1 shows the MALDI-TOF spectra of 
mutant GA470. .A.s expected all samples gave almost the same molecular mass. ~o6.2 
kDa, and mutant GA470 enzyme prepartion gave a single band on 12% SDS-PAGE gel 
(data not shown). 
Crystallization experiments using GA470 were immediately successful. Although 
small crystals appeared within a few days, crystal growing conditions were adjusted by 
varying protein and polyethylene glycol concentration to obtain crystals of mutant GAs 
Table 1. X-ray Data Collection and Refinement Statistics for Glucoamylase Mutants 
Data Collection N20C/A27C N20C/A27C/G137A N20C/A27C/S30P/G137A 
Cell dimensions (P2,2,2,)(A) 
a 110.1 110.3 109.3 
b 73.9 73.7 73.6 
c 62.6 62.8 61.4 
Resolution limit (A) 2.5 2.4 2.3 
Number of Structure factors used 22813" 27246" 25118" 
in refinements 
R™.,. (on I) 0.0816 0.0712 0.0661 
Total number of atoms 5218 4981 5208 
Total number of solvent sites 201 112 180 
Refinement 
0.25 0.26 0.24 
D C 
•^fwotk 0.19 0.23 0.20 
Mean B (A') for protein and 14.5 19.1 16.2 
glycans 
r.m.s of dev (bond: A) 0.010 0.012 0.009 
r.m.s of dev (angle; A) 1.44 1.46 1.43 
* Comprises all observed moduli from 8 to 2 A for resolution with 1 | > 2a 1 F,,^, | 
''Comprises all observed moduli from 6 to 2 A for resolution with | F,,^, I > lo | F^^^ | 
' Rffce/work ~ ^ I ^obs" 'Peal I ^ ^ ^ obi where F^^, and F„, are the observed and calculated structure factor amplitudes 
and the sums are over either work or test reflections. 
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that measured approximately 0.3 nm in length and 0.2 nm in diameter. These crystals 
gave diffraction data to 2.3 to 2.5 A (Table 1). The lattice type was orthorhombic with 
average unit cell dimension a= 109.9 A. b=73.7 A and c=62.3 belonging to a space 
group of P2i2i2i. The average unit cell volume of the protein was 4.83" 10" k^. .Assuming 
that 45% of the crystal volume wjis water, the volume of the protein was approximately 
2.6571 A^. In the P2i2i2i space group, the volume of protein in one cisymmetric unit 
Wcis 6642 .4^. From amino acid and carbohydrate composition the specific volume of 
GA470 weis 0.7029 mg/g. Therefore, the molecular mass in one cisymmetric unit was 
56893 Da. Since the molecular mass of GA470 is approximately 56.2 kDa. there was 
only 1 molecule of GA470 in the asymmetric unit. 
GA cDNA of .4. awamori origin was used to produce mutant G.A.470 for crystal-
lographic studies. However, native GA470 from A. awamori var. XlOO species was 
used in all prior structural work [20,58.59]. .\mino acid sequence alignment between 
,4. awamori and .4 awamori vaj. XlOO (up to position 470) reveals that two protein 
sequences differ in twenty-four positions; twenty-three single amino acid replacements 
and one amino acid deletion. We have adapted the amino acid numbering of prior work 
[20.58.59], which is based on the sequence of GA from A. niger . 
The three dimensional structures of the recombinant catalytic domain of three ther­
mostable mutants have been determined. The refinement statistics are summarized in 
Table 1. At the '2a level of the final 2|Fo|-|Fc|exp(iQca/) map all protein atoms have 
well defined density for N20C/A27C/S30P/G137A from residue 1 up to 463 and for 
N20C/A27C/G137A and N20C/A27C from residue 3 up to 463. The diffuse densities 
for the first two residues and last six residues were observed by Aleshin et al. [58]. A good 
indicator of the steriochemicaJ correctness for the model is provided by Ramachandran 
plots [163] (Figure 2). Most of the residues (>90%) fall in the most favored regions of the 
Ramachajidran plot with a few exceptions, Asn313 and Ser411 for N20C/A27C/G137A 
and N20C/A27C. Local hydrogen bonding networks imposed upon residues Asn313 axid 
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Ser411 offset unfavorable backbone angles as noted in previous structures [58]. Modeling 
suggests two probable alternative conformations for the side chain of residue Asn69. but 
only one conformation is presented in the current model. In one conformer. ND'2 of 
69 makes a hydrogen bond with water 661 which, in turn forms a hydrogen bond with 
carbonyl 433 and water 535. and ND2 also forms a strong hydrogen bond with carbonyl 
65. In another conformer. MD2 of 69 hydrogen bonds with water 661. 
Secondary structure and topology of mutant G.As: The assignment of secondary 
structure was defined by PROCHECK [161]. Right handed helices present in the model 
are made up of a single connected run of at least four residues having o and v angles 
that fall within ±25° of the canonical values of <p=-65° and Ti'=-42°. There are thirteen 
a-helices. as observed in .4. awamori vaj. XlOO GA47I [20.58]. spanning residues I to 
19. 53 to 67. 75 to 89. 127 to 144. 148 to 168. 186 to 205. 211 to 225. 247 to 253. 272 
to 283. 318 to 337. -348 to 354. 368 to 390 and 416 to 429. .A.s expected four disulfide 
bonds exist in all three mutant G.'V molecules (one more than in the wild type enzyme). 
In mutant GAs. an additional disulfide linkage was introduced between residues 20 and 
27 (see below). The other disulfide bonds are between residues 210 and 213. 262 and 
270 and 222 and 449. In ail three GA mutant proteins we observe cts -peptide bond 
between Gly23-Ala24, Asn45-Pro46 and Argl22-Pror23. 
Approximately 29% of the residues in each thermostable mutant GA belong to reverse 
turns. To be consistent with descriptions of prior GA reverse turns, we have adopted 
the Lewis criteria in assinging reverse turns in mutant GAs. According to the Lewis 
criterion of reverse turns, the distance between the C° of residue i and C" of residue i4-3 
is less than 7 A, the central residues are not helical and have the allowed dihedral angles 
given eaxlier [164]. For all three thermostable GA mutants 46 turns were located and 
listed in Table 2. Of the classic /3-turn types, the type I turns are strongly favored (72% 
turns axe type I). Hydrophobic amino acids occur less frequently while hydrophilic side 
chains are frequent. A hydrogen bond was assigned in 27 out of 46 turns if the distance 
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Table 2: Turns located in mutant GAs from X-ray structure analysis. 
Residue 
Number 
Amino acid 
sequence 
Distance (A) 
O,-N, C,®-C4" 
0 . 9  
i + 1 
0. (P 
i + 2 
Turn 
Type 
19-22 LCNI 3.22 5.21 -71.-14 -106. 14 I 
23-26 GADG 4.98 5.40 -73,-10 -no. 12 ND 
26-29 GCWV 3.21 5.31 -60, -16 -113. 12 1 
29-32 VPGA 3.12 5.83 -66,128 120. 26 n 
33-36 DSGI 3.12 5.56 -63,125 84. 13 n 
43-44 TDNP 6.72 6.51 -156.136 44. 66 ND 
44-46 DNPD 4.58 4.36 44,66 -98. 167 g 
67-70 FRNG 3.19 5.43 -69,-18 -92. 18 I 
68-71 RNGD 6.03 6.88 -92. 18 120. -13 g 
93-96 NPSG 3.0 5.35 -58, -23 -82. -23 I 
97-100 DLSS 3.92 5.95 -77, -39 -53, -41 I 
98-101 LSSG 2.85 4.43 -53,-41 -88.-23 I 
101-104 GAGL 3.24 5.94 -62. -29 -66,-20 I 
102-105 AGLG 3.24 5.85 -66. -20 -68. -21 I 
110-113 NVDE 3.03 5.50 -65,-15 -95. 17 I 
169-172 YWNQ 3.19 5.48 -60. -40 -82, 21 I 
176-179 DLWE 2.79 5.03 -64, -20 -88, -6 I 
229-232 TGSF 5.67 5.63 116. -14 -142,-19 e 
236-239 NFDS 4.32 6.38 -90. 129 90, 55 If 
253-256 IHTF 3.57 4.99 -86, -5 -122. 13 I 
257-260 DPEA 3.02 5.35 -62,-13 -103.12 I 
263-266 DDST 3.71 5.86 -74, -31 -63. -28 1 
264-267 DSTF 3.16 4.66 -63. -28 -113, 10 1 
268-271 QPCS 3.01 5.22 -49, -37 -79, -24 I 
284-287 SFRS 4.92 6.44 -108,-10 -61.-39 1 
285-288 FRSI 3.57 5.27 -61,-39 -94, -22 I 
286-289 RSIY 4.58 6.43 -94. -22 -86.-17 I 
289-292 YTLN 2.98 5.39 -65,-25 -65. 25 I 
290-293 TL2>ro 3.22 5.33 -63.-25 -95. 8 I 
292-295 NDGL 3.63 6.03 -72, 135 84. 15 n 
296-299 SDSE 2.89 5.31 -67,-14 -96. -4 I 
306-309 YPED 3.29 5.62 -58, -28 -97. 16 I 
310-313 TYYN 2.85 4.43 -62. 115 63. 26 n 
311-314 YYNG 2.97 5.03 63. 26 91. -9 r 
312-315 YNGN 5.07 7.00 91.-9 86. 64 I" 
344-347 TDVS 3.32 5.18 -64.-32 -72. -46 f 
355-358 YSDA 3.08 5.61 -55. -33 -85. 19 I 
364-367 SSSS 3.17 5.62 -61,-27 -76.-23 I 
393-396 ASNG 2.81 4.94 -58,-29 -95.10 I 
403-406 DKSD 3.71 5.50 -63,-16 -110.-45 
404-407 KSDG 5.83 6.13 -110.-45 -122,-8 r 
412-415 ARDL 4.32 6.14 -82.154 43.53 If 
438-441 GETS 3.23 5.73 -60.-39 -61.-15 I 
439-442 ETSA 2.86 5.36 -61,-15 -115, 13 I 
440-443 TSAS 5.13 6.08 -115. 13 -151, 51 r 
446-449 PGTC 5.04 6.76 -58. -45 -125. 133 r 
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between CO group of residue i and NH group of residue i+3 is 2.5 to 3-5 The mirror 
image type I' was rare, observed only twice out of 46 turns and this trend is consistent 
with other proteins [165]. Two N-glycosylation sites. .A.snl?! and .AsnSOo. are also in 
type I turns, and these turns are e.xposed at the protein surface. Two .\'-glycosylation 
sites in rhamnogalacturonase A also reside in turns, implying that turns are important 
for glycosylation [166]. 
In this report, we are presenting three mutant protein structures determined by X-
ray crystallography. Figure 3 presents the refined model of the N20C/.A.27C/S30P/G137 
mutant, showing the mutation sites. As the mutant proteins considered here differ 
from wild-type enzyme by at most three amino acid residues, it was anticipated that 
their overall structures would be quite similar. We calculated difference maps bcised on 
(Fo6s(mu£)"^oi>3(«'0)^'^P('®'i«) three mutants and each of the three difference map shows 
differences predominantly localized around the mutation sites. The structural changes 
associated with each mutant are discussed below. 
In the vicinity of residues 20 and 27. each of the three difference electron density maps 
between mutant and wild-type enzyme showed one large positive peak, corresponding 
to the scattering of the disulfide bond (Figure 4). Moreover, omit maps at the position 
20 and 27 show bilobate positive difference density with a peak-to-peak separation of 
~2 .4. agreeing with expected sulfur-sulfur distance (2.05 A). .A difference map showed 
two large negative peaiks at the position occupied by the side chain atoms of residues 
Asn20 and Ala27 of the wild type enzyme, indicating that replacement of .•\sn20 and 
Ala27 with cysteine residues. We have also observed smaller positive peaks along the 
backbone atoms of residue 24. indicating that a shift of this residue due to the disulfide 
bond in the mutant structure. These features all indicate that a disulfide bond between 
residues 20 eind 27 is formed in ail three mutants. 
Figure 5 shows electron density coverage of the final refined structure of residues 
20-27. In the three mutants the engineered 20-27 disulfide bond adopts a right-handed 
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conformation. The average disulfide dihedral angles of three mutants are \,=-77° and 
\2=-113°. \i=88"' and \2=-93°. where \2 value deviates substantially from its referred 
value of -166°. However, all other dihedrcil angles are very close to that observed in 
other proteins [167]. The average sulfur-sulfur torsion angle of three mutants is \3=96°. 
which is close to the expected value of 99°. Other than \2 values, the engineered 20-27 
disulfide bond is undistorted and its bond length and angles are close to values, which 
putatively represent the conformation of lowest energy. 
Naturally occurring proteins possess both left-handed (\3=-90°) and right-handed 
disulfide bonds. (V3=90°) [168. 169]. While the left-handed disulfide bond in proteins 
cluster about a preferred geometry, the right-hajided disulfide groups show a wide \'ari-
ation in their dihedral angles [167]. Katz and Kosiaicoff calculated dihedral energy of 
84 disulfide bonds and found that the average dihedral energy' for the left-handed type 
is between 0.54 to 4.66 kcal/mol, and that of right-handed type is between 1.13 to 
4.02 kcaJ/mol [167]. Similar calculations with all three glucoamylase mutants gives an 
average dihedral energy of 4-5 kcal/mol for the engineered 20-27 disulfide cross-link. 
Calculations of dihedral energy involves only dihedral angles of S-S bond and do not 
consider bond lengths and van der VVaals contacts. However, the calculation gives an 
approximate idea of the amount of strain in 20-27 disulfide bond. The preference is to 
engineer disulfide bonds with minimal dihedral energy; however, it has been observed 
that a disulfide bond with non-optimai geometry may still markedly increase protein 
stability [170]. 
The stabilizing effects of a disulfide cross-link result from a decrease in flexibility 
and conformational entropy of the unfolded molecule [171-174]. We have calculated the 
effect of a cross-hnk on the conformational entropy (AS) using the following equation. 
( 1 )  
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where R is the universal gas constant and n is the number of bonds in the loop enclosed by 
the cross-link [l~o]. According to equation 13. the expected entropic stabilization of loop 
20-27 is 2.5 kcal/mol at 25°C. However, this entropic stabilization would be somewhat 
offset by I) the disruption of preexisting interactions in the wild-type structure due 
to new cysteine residues and 2) dihedral energy associated with the formation of the 
disulfide bond in the folded protein (discussed above). 
The crystallographic thermal parameters Bj of an atom j is related to U as follows 
Bj=87r2Uf (2) 
where Uj^ is the mean square amplitude of vibration. Bj values are indicators of structural 
flexibility or static disorder. The temperature factor for wild type and mutant enzyme 
were averaged for the main-chain and side-chain atoms of each amino acid (Figure 6). 
The overall mean thermal parameters for wild type. N20C/.A.27, N20C/.'\27C/G137A 
and N2GC/A27C/S30P/G137.A. enzymes are 16.1. 14.5, 19.2 axid 16.2 respectively. 
These relatively low numbers indicate that these structures are compact and rigid, Q-
Helices have the lowest temperature factors and reflect the rigidity of the core. Loop 
regions show higher B values than the core. Structural studies indicate that the in­
troduction of disulfide bonds sometimes imposes rigidity on a protein structure and 
sometimes it does not. Although position 20 is located at the N-terminal end of helix 1. 
position 27 is located in a large loop comprising residues 21-49. The thermal parameters 
in and around loop 20-27 of the refined wild-type and mutant structures are very similar, 
however, indicating that the added disulfide bond did not add rigidity to loop 20-27. 
Similar results have been observed in a crystallographic study of chemically cross-linked 
RNase A [176]. The mutation at position 30 also located in the loop 21-49, however, 
was a significant influence on B-values as mutant P30 has an average B of 12 relative 
to 20 for the wild type S30. 
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While we hoped that amino acid substitution in the wild-type structure would give 
thermostable, catalytically active enzyme, we assumed that the mutations did not affect 
significantly the three-dimensional structure of the protein. We have tested this assump­
tion by determining the crystal structure of single, double and triple point mutants of 
glucoamylase. The refined structure of the mutant is very similar to that of wild-type 
glucoamylase. except in the immediate vicinity of mutations N20C/A27C. S30P and 
G137A. The unit cell parameters of the crystals of the mutants and wild-type enzymes 
are almost identical within experimental error. Differences in the main chain coordi­
nates (Cq. N and C) between the mutant and wild-type structures were analyzed by 
superposition as implemented in the program LSQMAN [177]. The root-mean-square 
displacements for main chain coordinates between superimposed structures appears in 
Table 3. As inferred by difference maps, there are few differences in the structures. 
The r.m.s deviation of main-chain atoms between wild-type and mutant enzymes are 
0.238, 0.269 and 0.292 for N20C/A27C, N20C/A27C/G137A and N20C/A27C/S30P/ 
G137.A.. respectively (Table 3A). The coordinate error for each mutant structures is about 
0.2 A on the ba^is of Luzzati plots [178]. .A.lso. the r.m.s. delta B for matched atoms are 
in the range to 3 to 6 .A.^. and the linear correlation coefficient of the B-values of matched 
atoms are between 0.93 to 0.94, indicating that structures are equally refined and are 
accurate. The structures of wild-type and mutant enzymes in the vicinity of the mu­
tations are superimposed in Figure 7. Some small structural adjustments are observed. 
Therefore, we calculated r.m.s. deviations for all atoms within 6 A of the mutation sites 
(Table 3B). To further investigate the conformational change around each mutation site, 
the r.m.s. deviation from residues 19 to 29, 28 to 32 and 134 to 140 were compiled and 
presented in Table 3C. As expected, the largest deviation occurs at the mutation sites 
and the deviations are above the level of the standard deviations of the coordinates. 
The proline at position 30 adopts a favorable conformation (<p = -64°). The main-chain 
atoms of Pro30 moved ~0.4 A, along with the movement of the side chain atoms of 
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residues 2S to 32 by 0.6 A (Table 3C). Mutation of Glyl37. which is in helix 4. to Ala 
caused movement of backbone atoms by 0.4 A. However, this mutation does not have a 
significant effect on other residues within 6 A from the site of mutation. 
The hydrophobic effect, as proposed by Kauzmann in 1959. is believed to play a 
major role in protein folding [179]. After protein folding, most of the non-polar amino 
acid side chains are removed from the aqueous environment and reside in the interior 
of the molecule, shielding themselves from solvent. This relationship between amino 
acid residues ajid water has been quantitatively explored by Lee and Richards, who 
developed the concept of accessible surface area [108]. The accessible surface area (.AS.A.) 
of a residue is obtained by summing the accessible surface area of its constituent atoms 
using their methods as implemented in the program NACCESS [ISO], the group radii 
of Chothia [181] ajid a probe radius of 1.4 A. The solvent accessibility of individual 
amino acids of a protein gives aa indication of residues buried in the interior or exposed 
to the solvent. The solvent accessibility of an individual residue is correlated with 
its hydrophobicity [182]. We have applied this concept to calculate the free energy of 
the hydrophobic interactions of the mutant enzymes. Table 4 reports the surface area 
exposed to solvent for the side chains of residues 20. 27, 30 and 137 for wild-type and 
mutant enzymes. Mutanttions at these sites bury 11.0. 25.1 17.0 and 28.5 A^ more 
surface area, respectively, than wild-type glucoamylase. .A. change in .AS.^ values may 
play aji important role in conformational stability of the mutant proteins. We have used 
a conversion factor of 24 cal/(A^.mol) from Chothia to calculate the free energy change 
of stabilization due to the hydrophobic effect [182], and the results are tabulated in 
Table 4 under the column heading AGkcai- As expected all mutations are stabilized by 
hydrophobic interactions and the most prominent hydrophobic effect is for G137A. As a 
control, we have also calculated the solvent accessible surface area of six residues adjacent 
to mutation sites but did not find any significant free energy change of stabilization due 
to hydrophobic interactions. 
Table 3: The R.M.S. deviation (A) of atoms between the wildtype and mutant structures 
A. Overlapping the structure with CA, N and C atoms 
N20C/A27C N20C/A27C/G137A N20C/A27C/S30P/G137A 
Av. displacement (A) 0.267 0.238 0.292 
No. of Residue superposed (A) 464 464 464 
Corelation coefficient of matched B atoms (A) 0.933 0.983 0.944 
RMS delta B of matched atoms (A) 6.269 2.961 3.689 
B. Atoms within 6 A of mutation site 
N20C/A27C N20C/A27/ G137A N20C/ A27C/S3 OP/G137A 
20C/27C 20C/27C 0137 A 20a27C 30P 137 A 
Total No. of atoms 76 76 36 76 36 49 
All atoms 0.412 0.549 0.248 0.489 0.318 0.243 
Main chain atoms 0.406 0.444 0.224 0.535 0.323 0.244 
CA atoms 0.360 0.488 0.228 0.576 0.330 0.252 
side chain atoms 0.428 0.330 0.275 0.351 0.636 0.216 
Table 3 (continued) 
C. Superposition with wildtype using main chain atoms CA, N and C. R.M.S 
deviations from residues 19 to 29, 28 to 32 and 134 to 140 are presented. 
Residue N20C/A27C N20C/A27C/ N20C/A27a Residue N20C/A27C N20C/A27C/G1 N20C/A27C/ 
No. G137A S30P/G137A No. 37A S30P/G137A 
16 0.27 0.33 0.28 30 0.22 0.27 0.42 
17 0.17 0.17 0.16 31 0.13 0.18 0.37 
18 0.12 0.21 0.18 32 0.07 0.19 0.14 
19 0.12 0.19 0.20 33 0.16 0.13 0.15 
20 0.14 0.25 0.32 34 0.37 0.31 0.37 
21 0.12 0.24 0.21 35 0.30 0.27 0.10 
22 0.09 0.07 0.28 134 0.24 0.21 0.13 
23 0.91 1.28 1.40 135 0.27 0.19 0.18 
24 0.22 0.53 0.76 136 0.18 0.15 0.14 
25 0.16 0.27 0.25 137 0.14 0.49 0.37 
26 0.12 0.26 0.42 138 0.16 0.11 0.28 
27 0.57 0.51 0.63 139 0.18 0.14 0.26 
28 0.24 0.21 0.32 140 0.23 0.15 0.30 
29 0.27 0.28 0.34 141 0.13 0.10 0.34 
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Table 4 " Calculation of hydrophobic free energy of stabilization 
Amino Acid Ao A 
<
 1 0 
<
 ^Gkcal AAG(,v/uf-U-T) 
.•\sn20 143.9 31.2 112.7 2.71 -
Cys20 1.34.3 10.6 123.7 2.97 0.26 
.•\la27 10S.3 S1.9 26.1 0.63 -
Cys27 134.3 83.1 51.2 1.23 0.60 
Ser30 116.5 100.1 16.51 0.40 -
Pro30 136.1 102.0 33.5 0.80 0.40 
Glyl37 80.1 3.70 76.4 1.83 -
.'\lal37 108.0 3.1 104.9 2.52 0.69 
"The accessible solvent surface area was calculated by the method of Lee 
and Richards [180], and is defined as that of the van der VVaals surface of 
the protein accessible to a spherical solvent molecule of 1.4 A radius. .\o is 
the solvent- accessible surface area of the residue in an extended (o=:-l40°. 
^•=135°) tripeptide Ala-X-Ala. However, when X was proline the conformation 
o=-77.2°, «;=145.9° was adopted. A is the solvent accessible surface area in 
the folded protein. Aq-A is the area that is buried when enzyme folds. AGcai 
is the calculated free energy of folding obtained by multiplying .\o-A by 24 
cal/(A-.mol) [182]. The AAG(iv/u, _VVT) is the calculated free energy due to 
the mutation. The coordinates for the ciccessible surface A were from refined 
crystal structures. 
S.30P: The difference electron density map at the S30P site shows expected negative 
features, which correspond to the loss of the serine side chain and positive density due 
to the introduction of the pyrrolidine ring of Pro30. The proline residue at position 
30 is a trans isomer of the preceding peptide, where o. and v values of proline axe -
64.7° axid 131.0°, respectively. These values are in close agreement with trans- proline 
conformations, 0 is -63° and w is -35° and 150° [183]. In the wild-type structure, OG of 
Ser30 makes a long hydrogen bond (N- • -0 distance is 3.5 .4) with the amide nitrogen 
of residue 31. However, in the mutant structure with a proline at position 30, where 
nitrogen is part of the pyrrolidine ring, the hydrogen bond involving OG cannot be made. 
The pyrrolidine ring at position 30 is puckered, as heis been observed in other pyrrolidine 
rings in the refined structures (there are 15 prolines in the glucoamylase model). In both 
the refined and modeled structures, the distances from the cJ-carbon of the pyrrolidine 
ring to the amide nitrogen of Val29 are the same i.e., 3.1 A. The superposition of 
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the refined mutant structure onto the wild-type structure indicates that the respective 
backbone conformations are very similar (Table 3A). However, superposition based on 
side chain atoms gives an r.m.s. deviation of 0.6 A. and this is due to the difference in 
the side chains of Ser and Pro (Table 3B). The temperature factor is lower at the mutant 
site for Pro30 than it is for the wild-type enzyme at SerSO (12 versus 20 .Also 
accessible surface area as calculated by NACCESS reveals that residue 30 buries ~17 
more area when serine is replaced by proline, giving a net 0.4 kcal/mol free energy of 
stabilization due to the S30P mutation (Table 4). Serine is more hydrophilic than proline. 
Therefore. S30P should decrease loccd hydrophilicity and increase hydrophobicity. 
The backbone conformation of proline in proteins is severely restricted compared 
with other amino acids. .As a consequence, the S30P mutation decreases the backbone 
conformational entropy at the site of mutation. Schimmel and Flory's energy calculation 
have shown that five member rings of proline also restrict the available conformational 
space of the preceding residue [184]. These studies imply that Xxx—>Pro mutations can 
reduce the backbone entropy of unfolding [149]. The backbone entropy contribution 
from such mutations can be calculated using the following equation. 
ASj.y = ASconf(Z) — ASconf(Y) = Rln— (3) 
lY 
where AS is the configuration entropy of residue Y and Z and ASz.v is their difference. 
R is the universal gas constant, jy and 7^ are the relative area in a conformation map for 
residue Y and Z, respectively. An estimation of the conformation entropy of unfolding 
of Ser30 relative to Pro30 is 3.8 cal/(deg.mol), which is a change of 1.3 kcal/mol of 
free energy of unfolding at pH 4.5 and 70.3®C. Therefore, the entropic contribution may 
increase the stability of mutzint glucoamylase. 
Ser30 met several criteria for proline substitution. The conformation of the backbone 
of Ser30 is (p, xp = 65.6°, 127°, which defines an allowed conformation for proline. As a 
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result there is a minimal structural change due to the mutation. Steric hindrance between 
the C''H2 (attached to the imide nitrogen of pyrrolidine ring) and the NH and C^H2 of 
the preceding residue. Var29 (distance from C''H2 to NH and C'^H2 of V'al29 is 3.11 and 
4..57 A. respectively). Consequently, the conformation of Val29. <d=-120° and f=49° is 
as predicted by Schimmel and Flory [184] and falls within the observed \'alues of (p=-4o° 
to -180° and r=25° to -80° and r=45° to 180° (Figure 6B of reference 182). .Although 
Ser30 met several important criteria for proline substitution in the wild-type structure, 
its side chain forms a weaic hydrogen bond (N- • -O distance 3.5 A) with the backbone 
residue 31. Notwithstajiding the loss of this hydrogen bond, the replacement of serine 
with proline still increcises the stability of the protein. Using the interactive graphics 
program TOM. we did not observe any unfavorable van der Waals contacts between 
the pyrrolindine ring and its neighboring atoms in the native protein. Interestingly. 
Pro30 follows the proline rule of Suzuki [140]. It occurs at the second position of a type 
II ^-turn and replacement of the partially solvent-exposed serine by proline increases 
the hydrophobicity at this site. Consequently, serine to proline substitution at site 30 
increases glucoamylase stability by increasing the hydrophobicity and decreasing the 
backbone entropy of unfolding by reducing backbone flexibility. 
The importance of proline in protein thermostability has been well documented. 
Matthews et al. demonstrated improvement of T4 lysozyme stability by introducing 
proline in /3-turns [149]. This follows a number of other reports where single proline 
substitution increased stability of hen egg lysozyme [185] and Bacillus cerus ATCC 
7064 oligo-l,6-glucosidase [186]. There are, however, other examples where improper 
placement of proline significantly decreases protein stability e.g., L66P and L9IP mu­
tants in T-4 lysozyme [172]. These are examples of proline replacement that did not 
meet the criteria for proline selection sites mentioned earlier. 
G137A: The electron density map showing the difference between G137A and wild-
type glucoajnylase is shown in Figure 4E. As expected, there is a new positive density 
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at the mutation site and the rest of the map is virtually featureless, indicating that the 
mutant structure is very similar to that of wild-type enzyme. In the G137A structure 
the lFo|-|Fc| electron density is well defined (Figure 5E). AIal37 occupies the space of 
the former Glyl37. The positions of the neighboring amino acids Ilel36 and Phel3S are 
almost unchanged. Alal37 hcis average 0 and f values of -66.1° and -35.7°. which have 
changed slightly from the values of -61.0° and -43.1° for the wild-type protein. The 0 and 
w values of Alal37 are within the right-handed a-helical region of the Ramachandran 
map. The Alal37 Cg makes van der VVaais contacts (<4 A) with the carbonyl oxygens of 
Thrl33 and .A.lal34. which necessarily are absent in the wild-type enzyme. The average 
r.m.s. difference for all atoms, main chain atoms. CA atoms and side chain atoms 
for residues within 6 A of the mutations is 0.21 to 0.25 A. which is the same cis the 
estimated RMS coordinate error of 0.25 A obtained by the method of Luzzati [178). 
Glyl37 is located in helix-4. which is one of the inner set of helices, and it interacts 
significajitly with helices-3, -5 and -6 (Khan. S. M. .A... unpublished data). The solvent 
accessible surface area of Glyl37 is almost negligible, about ~5%. Upon .-Ma substitution 
at 137. it buries 28 A more surface area compared with Gly. indicating that the Gly 
to Ala replacement contributes 0.69 kcal/mol of free energy of stabilization (Table 4). 
The burial of the alanine side chain (-CH3) upon folding contributes to the hydrophobic 
effect of glucoamylase stability [187]. .\lanine has similar size and polarity to glycine, 
thereby minimizing the chance of disrupting the folding and expression level of the 
mutant proteins. Also, Alanine buries more solvent accessible hydrophobic surface area 
on folding from an extended conformation than does glycine [188]. It has been observed 
that glycine is preferred at N and C caps of the a-helix, but alanine placed over glycine by 
0.4 to 2 kcal/mol [189]. .Alanine's small side chain reduces the possibility of introducing 
unfavorable van der Waals contact. Alanine frequency is about 52% within Q-helices 
[190]. On the other hand, glycine is known to be helix destabilizing because it stabilizes 
the unfolded state by its additional degrees of conformationai flexibility. Consequently, 
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amino acid replacement of the form Gly—>^Ala would decrease the conformation entropy 
of the unfolded state, resulting an increased stability for the protein. Equation 1 is used 
to calculate the relative entropy of unfolding of Glyl37 with respect to .A.lal37. which 
is -2.3 cal/(deg.mol). corresponding to a change of 0.79 kcal/mol in the free energy of 
unfolding at 70.3°C and pH 4.5. 
Additivity 
When one or more mutations axe combined in a single protein, the resulting molecule 
may or may not exhibit the sum of the properties of the constituent mutations. In gen­
eral. if the mutations introduces only local structural chajige and are far from each other, 
then most likely the addition of each mutation in a single molecule would likely to have 
additive effects. On the contrary, nonadditivity indicates that there is some form of in­
teraction between different sites and/or changes in protein conformation caused by muta­
tion. In the case of the triple mutant N20C/A27C/S30P/G137A. the increase in ATm of 
3.9°C is approximately equal to the sum of ATm of N20C/.A.27C = 1.4°C. S30P = 1.7°C 
and G137A = 1.2°C [143.144,191]. Such additivity suggest that each substitution acts 
independently and that the mutation caused little change in the overall conformation of 
the protein. Wild-type and mutant structures determined by crystallography supports 
the view that the effects of the combined mutations in N20C/A27C/S30P/G137A are 
cumulative. In fact, comparison of mutant and wild-type structures shows that confor­
mational changes are local to the site of mutation. Such cumulative effects have also 
been observed in protein engineering of kanamycin nucleotidetranferase [192] and T4 
lysozyme [193]. The glucoamylase structure is very robust, as its conformation remciins 
almost the same at pH 4, 6 [58] and 8 and also in presence of the inhibitors acar-
bose, deoxynojirimycin and dihydroacarbose [59,61-63]. Therefore, glucoamylase may 
be an ideal taxget for protein engineering to produce a hyperstable enzyme by combining 
73 
promising individual mutations into a single molecule. 
Conclusion 
Native fungal glucoaxnylase may have evolved to optimize its biological function 
catalysis at physiological temperatures, 37°C. One way to increcise glucoamylase ther­
mostability is by the application of protein engineering technology. Once the thermally 
stable mutant is screened out, then the next logical step is to understand why the de­
signed molecule exhibits enhanced thermostability. The results from this study show that 
the increased stability from amino acid replacements can be attributed to hydrophobic 
interactions and decreases in backbone entropy of unfolding by reducing flexibility. In 
particular, the engineered disulfide bond adopts a near optimal geometry and provides 
hydrophobic stabilization. The replacement of Gly with Ala at site 137 of helix-4 heis 
also been shown to increase the thermal stability of glucoamyleise. In this instance, the 
enhancement of thermal stability has been achieved by replacing a poor helix forming 
glycine with a good helix forming alanine. Also it was estimated that reduction in 
entropy in the G137A substitution corresponds to a free energy change of 0.79 kcal/mol. 
Combining N20C, A27C, S30P and G137A clearly yielded a more thermostable pro­
tein. As a single mutation stabilizes glucoamylase by only a few degrees, it will be 
necessary to engineer more than four substitutions in a single molecule to produce a 
hyperstable enzyme that would be suitable for industrial applications. Clearly this is 
a reasonable strategy as far as the stabilizing effect of mutations are approximately 
cumulative. 
The studies also suggest a method that can be applied to study structure-properties 
of glucoaxnylase expressed in 5. cerevisiae : choose the mutant that shows interesting 
biological properties, subclone the mutation into glucoamylase cDNA that has an amber 
codon introduced at 470, purify protein through a single step acarbose column, crystallize 
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it and determine its 3-D structure. One can also consider multiple substitution in the 
same molecule, as we did in the present study before pursuing 3-D structures, as it would 
save considerable time. 
Figure Legends 
Figure 1: MALDI-TOF mass spectra of glucoamylase mutants, (A) N20C/A27C/ 
S30P/G137A, (B) N20C/A27C/G137A and (C) N20C/.'\27C. Each spectrum is the av­
erage of approximately fifty laser shots. 
Figure 2: Ramachandran plots for the refined glucoamylase mutants. (A) N20C/ 
A27C/S30P/G137A, (B) N20C/A27C/G137A and (C) N20C/A27C. The main-chain 
torsion angle <2^ (N - Ca bond) is plotted versus V* (Co -C bond). Glycines are plotted 
as circles axid all other residues as crosses. The enclosed areas of plot show sterically 
allowed angles. 
Figure 3; Schematic ribbon representation of N20C/A27C/S30P/G137A glucoamy­
lase mutant. The substituted residues are labeled as A137. P30 and S-S. The structure 
was solved to 2.3 A resolution. This figure was prepared with the program MOLSCRIPT 
[194], 
Figure 4: Part of the final difference map between mutants and wild-type glucoamy­
lase. Figures A, B and C are from N20C/A27C/S30P/G137A, D and E are from 
N20C/A27C/G137A and F is from N20C/A27C. The superimposed difference electron 
density is calculated with amplitude Fmut- Fwt, where Fmut and Fu,^ are the observed 
structure amplitudes for the mutant and wild-type structures, respectively. Phases are 
from the refined wild-type structures. Resolution is 1.8 A. The positive density is coun­
tered at a height of 3<T, where a is the root mean square density throughout the unit 
cell. 
Figure 5: The final 2|Fo|-|Fc| map superimposed on residues around mutation sites. 
Figures A, B and C are from N20C/A27C/S30P/G137A, D and E are from N20C/A27C/ 
G137A and F is from N20C/A27C. |Fo| is the structure factor observed for mutant, |Fcl 
to 
and phases a are from the final refined model. 
Figure 6: Plots of the variation of the average temperature factor for main-chain 
(top panel) and side-chain (bottom panel) of glucoamylase mutants, (A) N20C/A27C/ 
S30P/G137A. (B) N20C/A27C/G137A and (C) N20C/A27C. 
Figure 7: Least-square superposition of residues around mutation sites. Figures 
A. B and C are from N20C/A27C/S30P/G137A. D and E are from N20C/A27C/ 
G137A and F is from N20C/.A.27C. Solid ajid broken lines represent model from VVT and 
mutant structures, respectively. The protein atoms corresponds to those for the VVT. 
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CHAPTER 4: POSITIVE IDENTIFICATION OF 
GLYCOSYLATION SITES IN PROTEINS AND PEPTIDES 
USING A MODIFIED BECKMAN LF 3600 N-TERMINAL 
PROTEIN SEQUENCER 
A paper accepted by the Journal of Techniques in Protein Chemistry 
Xiaomei Lin. L. VVulf Carson. Saber M. A. Khan. Clark F. Ford and Kristine M. 
Swiderek 
Introduction 
Posttranslational modification such as the glycosylation of proteins and peptides can 
be ecLsily overlooked during conventional Edman degradation. L'sually, glycoamino acids 
appear as blank cycles during a sequencing run. Further sequence analysis is necessary 
after deglycosylation of the sample in order to assign the phenylthiohydantoin (PTH)-
Ser or Thr oligosaccharides {O -linked Sac) derivatives and the PTH-Asn (A- linked 
Sac), .Also, a consensus sequence of .A-sn-X-Ser (Thr) is an indication for PTH -Asn (A-
linked Sac) deri\'atives [195]. This kind of identification is a time and sample consuming 
task. Positive identification of the glycosylation sites during N-terminal sequence analy­
sis could become a real advantage. The techniques developed for the LF 3600 N-terminai 
protein sequencer (Beckman Instr.) provide a fast and efficient way to positively identify 
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Ser (Olinked Sac). Thr (0-linked Sac) and Asn {N- linked Sac) carbohydrate structures 
during N-terminal sequence analysis [196]. Liquid phase anhydrous trifluroacetic acid 
(TFA) is used to extract glycosylated, polar amino acid derivatives from the reaction 
cartridge. These amino acids are then converted into PTH derivatives, which can be 
positively identified during on-line chromatography. In addition, different forms of car­
bohydrate structures at a single amino acid site have different retention times and can 
be distinguished by further analysis [196]. After fraction collection of individual peaks 
during the chromatography of one sequencing cycle, the structure of oligosaccharides at 
one specific site can be further examined with subsequent analysis, such as mass spec­
tral analysis, capillary electrophoresis (CE) or high pH anion exchange chromatography 
(HP.-VEC). .Adding to the flexibility of the instrument, it can be switched back to regular 
mode for high sensitivity protein and peptide sequencing. This report will describe the 
use of a modified Beckman LF 3600 microsequencing system for the positive identifi­
cation of glycosylation sites of different protein and peptide samples. The analysis of 
glycopeptides from carcinoembryonic antigen (CE.A) will be presented. CE.A. is a heavily 
glycosylated membrane bound glycoprotein which has been intensively characterized as 
an important tumor marker for colonic cancer. The example for a glycoprotein is the 
starch binding domain (SBD) of the enzyme glucoamylase. which is an industrially im­
portant exoamylase used for saccharification of liquefied starch from various sources to 
produce glucose and finally fructose syrups [197j. For both. CEA and SBD. the identifi­
cation of the glycosylation sites is an important contribution to understand functionality. 
Material and Methods 
Sample Source: The protein asialoglycophorin (Sigma A 9791). which contains 
0 -linked Ser and 0 -linked Thr carbohydrate structures, is used as a standard for 
glycoprotein sequencing. Glycophorin (Sigma G-9511) can also be used as standard, 
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but desialation needs to be done prior to coupling in order to reniove sialic acid, q-
Lactalbumin (Sigma L-63S5) is used as a standard for high sensitivity sequencing as 
well as glycosequencing to compare the carcinoembryonic antigen (CEA) after diges­
tion with trypsin and chymotrypsin [198]. CEA was isolated and purified from liver 
metastcises of colon tumors as described elsewhere [199]. The enzyme glucoamylcise. 
containing an engineered enterokinase recognition site, was expressed and purified from 
yeast. Following the digestion by enterokinase. the starch binding domain (SBD). which 
contains 109 amino acid residues, was separated by gel filtration and desalted using a 
spin column [200]. 
Coupling Reaction: One prerequisite of the glycosequencing technique is the co-
valent attachment of the glycoprotein to a solid support. For these studies Sequelon-AA 
membrane disks (Perceptive Biosystem GEN920033) were used to attach the caxbonyl 
terminal groups of protein or peptide samples. Sequelon-AA is polyvinylidene difluoride 
(PVDF) membrane derivatized with aryl amino groups. To couple the sample, the mem­
brane is pre-wet with 5 /xl CH3CN and the sample volume of approximately 2G0pmol 
protein is applied to the disk and then dried 1 g of water soluble carbodiimide is dissolved 
in 100 jj. of coupling buffer as coupling reagent (available in the Sequelon-.A.A membrane 
kit). .After applying 0 ^1 of coupling reagent, the membrane is incubated for 30 minutes 
at room temperature. The disk is then washed twice with 50% methanol/H20 to remove 
the extra reagent. After coupling, the membrane is stored at 4°C in an Eppendorf tube. 
When samples are attached via carboxyl groups, the protein or peptide must first be 
desialated prior to the coupling reaction. This is necessary to prevent the coupling of 
terminal carboxyl groups of sialated glycoamino acids to the support and to increase 
the yield of glycoamino acids extracted during the Edman reaction. The desialation 
procedure is carried out according to Gooley et al. [196]. A cap cut from a 1.5 ml micro­
centrifuge tube WELS used as a reaction chamber. After the protein is dissolved in 40 fil 
of 0.1 M TFA (Pierce), the sample is incubated at 80°C for 40 minutes. The sample is 
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then dried in a vacuum centrifuge to remove TFA and resuspended in 20%CH3CN/H20. 
Glycosylation Analysis: The samples are applied to a modified Beckman LF 3600 
DT protein sequencing system (Beckman Instruments Inc. # 291106). Two cartridge 
block bottle positions are used for TF.4 delivery so either gas or liquid phase sequencing 
can be applied. Thus, the instrument can be easily switched to regular mode of high 
sensitivity protein analysis. The delivery tubing and the programming of the sequencer 
were changed in order to deliver liquid TF.'V through the valve block. Kel-F valves were 
added to the second TF.A delivery reservoir to prevent corrosion. PTH-derivatives of 
both amino acid and glycoamino acids are chromatographed using a Gold HPLC system 
equipped with a diode array detector at 268 nm range. The PTH derivatives of amino 
acids and glycoamino acids are separated by a custom made HPLC column (250x2.1 
mm. Hypersil) at 50°C with a flow rate of 0.2 ml/min. \ new buffer system is used, 
25mM ammonium formate, pH 4.0. as buffer .A., and 100% acetonitrile as buffer B to 
separate the different PTH-glycoamino acids a^ well as the PTH-amino acids. The stock 
solution for buffer .A. is made by adding 30% ammonium hydroxide (.Aldrich #33.881-8) 
to 88% formic acid (.Aldrich #39.938-8) with a final concentration of 250mM pH 4.0 
for ammonium formate and is stored refrigerated. A gradient for the separation of the 
PTH-derivatives is used according to the recommendation of the manufacturer. 
Figure l.A shows the chromatogram of 20pmol PTH-standard using the new chro­
matography system. The chromatogram represents the separation of a total of 19 PTH-
amino acid derivatives except for cysteine. In addition, the new buffer system expands 
the front region of the gradient for the separation of PTH-glycoamino acids. Figure IB 
is a representative sequence analysis of the commercially available glycoprotein cisiaJo-
glycophorin using the described glycosequencing method. 200pmole of the sample is 
coupled to a .AA-Sequelon membrane as described above prior to Edman sequencing. 
The first 14 cycles are displayed. Cycles 2, 3 and 4 shows peaks of PTH derivatives 
of Ser (0-linked Sac) and Thr (0-linked Sac). The glycoamino acids are identified by 
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a unique pair of peaks. For example, there are two resolved peaks of PTH-Ser (Sac) 
with retention times of 6.5 and 6.7 min in cycle 3 representing PTH-Thr (Sac) I and II 
with retention times of 6.9 and 7.3 min. The peak pairs have been shown to represent 
stereoenantiomers and can be present in different ratios [196]. In addition, different re­
tention times of the peak pairs can indicate different saccharide structures. The positive 
identification of glycosylation sites is still possible after 10 cycles: Thr (Sac) in cycles 
II. 12. 13 and Ser (Sac) is cycles 14. 15, 16 are still well distinguishable. In contrast, no 
sequence assignments for cycles 2. 3 and 4 and 11-16 can be made using the conventional 
sequencing method (data not shown). A. high background is observed in all cycles due 
to a high degree of impurity of the sample. SDS-PAGE analysis of this protein sample 
shows multiples bands on the gel (data not shown). 
To compare the glycosequencing procedure with the conventional high sensitivity 
sequence analysis, o-lactalbumin was sequenced in both modes. Figure 2A and B show 
cycles 1-3 and cycles 12-14 from conventional and glycosequencing analyses side by side. 
The features of each cycle appear to be similar for both runs, and the repetitive yields 
are appro-vimately the same. However, for the conventional high sensitivity sequence 
analysis, the low level of sample amount required is about lOpmol. as demonstrated in 
Figure 2C. The lowest amount that can be subjected to glycosequencing is about 50pmol 
(Figure 2B). .Also, the lower limit of glycoamino acid detection depends on the efficiency 
of the coupling reaction, which can vary for different protein and peptide samples. It 
should be noted that there is also an upper limit to couple samples to the membrane. 
For most of the samples, 200pmol has proven to be optimal for covalent coupling and 
further glycosequencing analysis. 
Using the glycosequencing technique, we were able to identify the glycosylated sites 
for several samples submitted to us for analysis. Figure 3 shows the sequencing results 
of the SBD domain of glucoamylase. Previous GS-MS studies had shown that only 
mannose is present in this protein [200]. About Inmol of sample is coupled to the 
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membrane disk. During subsequent glycosequence analysis, peaks with retention times 
of 6.5 and 7.5 in cycle 4 can be assigned to PTH-Thr (O-linked Sac). One of the retention 
times is different compared to those assigned for PTH-Thr (Sac) in asialoglycophorin. 
which indicates a different form of carbohydrate structure [196]. PTH-Thr (0-linked 
Sac) can also be identified in cycle 6. The carbohydrate structures linked to the Thr in 
this cycle are even more heterogeneous, which is indicated by the presence of three peaks 
with retention times of 6.5. 6.9 and 7.3 min. Examples of peptides containing PTH-Asn 
(.V- linked Sac) have been observed during the sequence analysis of fractions from the 
tryptic/chymotryptic digest of carcinoembryonic antigen (CEA). Figure 4A shows the 
sequence analysis of a CE.A peptide. The peak with retention time of 7.0 min in cycle 
2 is assigned as PTH-.^sn (.V- linked Sac). The sequence analysis of a different CEA 
peptide ais a example for Asn (N- linked Sac) in cycle 9 with a retention time of 7.0 min 
is observed. The identification of these glycosylation sites in CEA peptides is consistent 
with previous mass spectral analyses and deglycosylation experiments [198]. 
Conclusions 
Several examples using sequencing techniques developed for the positive identification 
of glycosylation sites of proteins and peptides are presented. The analysis is straight­
forward and less time and sample consuming then the previously described sequencing 
techniques. The technique requires extra steps such as the covalent coupling of the 
protein or peptide samples prior to the sequence analysis. However, the sequence mod­
ification and operation is easily applied on a routine basis. The HPLC system can be 
easily adjusted, resulting in good separations of PTH-amino acids and PTH-glycoamino 
acids. In addition, different carbohydrate structures attached to a single amino acid 
site can be distinguished. The different glycoforms collected from the HPLC can be 
further analyzed by LC/MS, GC/MS, high performance anion exchange chromatogra-
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phy (HPAEC) and capillary electrophoresis (CE) in order to obtain the information 
regarding the structures and heterogeneity of the oligosacchaxides. 
Figure Legends: 
Figure 17; (A) HPLC chromatogram of 20pniol PTH-amino acids using the current 
glycosequencing method. 19 PTH-amino acids are separated by a modified reverse phase 
HPLC system. (B) Sequencing results of asialoglycophoring using the glycosequencing 
method. 200pmol of sample were subjected to the analysis. The assigned PTH-amino 
acids of the 16 N-terminal residues of asialoglycophorin are LSTTG/EV.^MHTTTSSS. 
Figure IS: (.'\) Sequencing results of 30pmol Q-lactalbumin using the high sensitivity 
sequencing mode. The 15 N-terminal residues are assigned to be EQLTKCEVFRELKDL. 
(B) Sequencing results of a-lactalbumin using the glycosequencing mode. 200pmol of 
the sample is coupled to the .\.A.-Sequelon membrane prior to Edman sequencing. Cy­
cles 1-3 and cycles 12-14 are presented for both sequencing runs. (C) Sequencing results 
of lOpmol o-lactalbumin using the high sensitivity sequencing mode. Cycles 9-14 are 
shown. 
Figure 19: Sequence analysis of SBD domain using the glycosequencing method. 
Peaks in cycle 4 are PTH-Thr (Sac) with retention times of 6.95 and 7.40 min and those 
in cycle 6 are PTH-Thr (Sac) with retention times of 6.45. 6.95 and 7.25 min, respectively. 
The sequence of the first 15 amino acids is the peptide is SCTTPTAVAVTFDLT. 
Figure 20: Glycosequence analysis of different CEA peptides. (A) The analysis of a 
CE.\ peptide that contains .Asn (Sac) NO-linked carbohydrate structures in position 2 
is shown: SNNSKPVEDK. (B) The analysis of a CEA peptide that contains iV- linked 
carbohydrate structures in position 9 is shown. Sequence: FTCEPEAQNTTY. 
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CHAPTER 5: CONCLUSIONS 
Glucoamylase is relatively a big molecule of 616 amino acids long of molecular mass 
~S2 kDa consisting of two domains located at the N- and C-termini. Using directed 
mutagenesis technique. I was able to produce both modified catalytic (N-terminal) and 
modified starch binding (C-terminal) domains for characterization as well as thermal 
denaturation studies. N-terminal sequencing, amino acid composition analysis. MALDI-
TOF. and sedimentation equilibrium experiments suggest that both the catalytic and 
the binding domains have produced, with molecular masses of ~56.2 kDa and 12.5 kDa. 
respectively with a carbohydrate content of ~r2% and 5%. respectively. GC/MS studies 
on SBD and its 161-162 Da mass unit difference in M.-\.LDI-TOF spectra indicates the 
presence of mannose residues. Temperature denaturation experiments indicate that the 
catalytic domain unfolds irreversibly, whereas starch binding domain unfolds reversibly. 
with AH values of ~410 and 71 kcal/mol. respectively, and Tm of 60.9° and 51.3°C. 
respectively. .Analysis of DSC scan rate dependency data suggest that the thermal un­
folding of G.A.470 was partially under kinetic control and did not follow a single two-step 
irreversible model. Comparison of of isolated and intact GA470 and SBD indicates 
that catalytic domain either itself/or in conjunction with the linker thermally stabilizes 
the binding domain by at least 5°C. A solvent accessible surface area calculation along 
with experimentally determined AH values indicate that glycosylation affects AH as 
much as 59 kcal/mol for GA47G and 13 kcal/mol for the SBD. 
Glucoamylase is a very important industrial enzyme being placed second in world­
wide distribution and sales among industrial enzymes [25]. When glucoamylase is used 
I l l  
in industrial settings, it exhibits a number of hmitations. One of them is that the enzyme 
is unstable above 60°C. As a result, saccharification is done at a relatively low tempera­
ture and in digestion mixtures of high viscosity, which makes the glucoamylase digestion 
of oligosaccharadies rate limiting in glucose syrup production. This necessitates the 
engineering of thermostable GA e.g.. N20C/.'\27C/S30P/G137A. It wzis the goal of the 
author to understand why the engineered molecule is thermally more stable than the 
wild-type enzyme. I have subcloned the DNA fragments harboring these mutations into 
a glucoamylase cDN.A. that already had a stop codon at 471. This allowed me to produce 
crystallizable N-terminal protein fragments for crystallographic studies. In this way. I 
was successful in obtaining high resolution 3-D structures of three thermostable glu­
coamylase mutants: N20C/.A27C. N20C/.-\27C/Gl37.A and N20C/.*\27C/S30P/G137A. 
These studies indicate that the increzised thermal stability from amino acid replacements 
can be attributed to increased hydrophobic interactions and decreases in backbone en­
tropy of unfolding by reducing flexibility. In particular. I found that the engineered 
disulfide bond is right-handed albeit with average strain energy of 4 kcal/moi. The sub­
stituted proline at site 30 increases the local hydrophobicity and tightened the type II 
i-turns as revealed by decreased temperature factors (12 .-X. versus 20 .\ at P30). Except 
at Pro30. I did not observe any significant change in temperature factors among all the 
mutants relative to the wild-type glucoamylase. Structural studies also reveal that the 
Gly—^.Ala replacement at site 137 is accommodated within helix-4. and it Wcis estimated 
that reduction in entropy in G137.\ substitution corresponds to a free energy stabiliza­
tion of 0.79 kcal/mol. .A.lthough the overall structures of the mutants are very similar 
compared to the wild-type glucoamylase. there are some local conformational differences 
as indicated from r.m.s. deviation values calculated within 6 .4 from the mutation site 
(Table 3 of chapter 3). This study also supports the experimental findings that the 
effects of combined mutations in N20C/A27C/S30P/G137A are cumulative. 
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